- - 20000000 --12-31 0.01 2022 - 0.01 100000000 false - 35066251 35398610 0001518621 Q3 - - - - - - - - ☒ ☒ 0001518621 2021-01-01 2021-09-30 0001518621 2021-12-31 0001518621 2022-01-01 2022-09-30 0001518621 2022-09-30 0001518621 2022-07-01 2022-09-30 0001518621 2020-12-31 0001518621 2021-07-01 2021-09-30 0001518621 us-gaap:CashMember us-gaap:RepurchaseAgreementsMember 2022-09-30 0001518621 us-gaap:CashMember 2022-09-30 0001518621 orc:PayerSwaptionMember 2022-09-30 0001518621 us-gaap:RepurchaseAgreementsMember 2022-09-30 0001518621 us-gaap:RepurchaseAgreementsMember 2021-12-31 0001518621 us-gaap:InterestRateSwapMember 2021-12-31 0001518621 orc:ToBeAnnouncedSecuritiesMember 2021-12-31 0001518621 us-gaap:DividendDeclaredMember 2013-01-01 2013-12-31 0001518621 us-gaap:DividendDeclaredMember 2014-01-01 2014-12-31 0001518621 us-gaap:PerformanceSharesMember 2022-01-01 2022-09-30 0001518621 us-gaap:PerformanceSharesMember 2021-12-31 0001518621 us-gaap:PerformanceSharesMember 2022-09-30 0001518621 us-gaap:PerformanceSharesMember 2020-12-31 0001518621 us-gaap:PerformanceSharesMember 2021-01-01 2021-09-30 0001518621 us-gaap:DividendDeclaredMember 2022-01-01 2022-09-30 0001518621 us-gaap:DividendDeclaredMember 2015-01-01 2015-12-31 0001518621 us-gaap:DividendDeclaredMember 2013-02-13 2022-10-28 0001518621 us-gaap:RepurchaseAgreementsMember us-gaap:ResidentialMortgageBackedSecuritiesMember orc:PassThroughCertificateMemberMember 2021-12-31 0001518621 us-gaap:RepurchaseAgreementsMember us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:StructuredFinanceMember 2021-12-31 0001518621 us-gaap:DividendDeclaredMember 2016-01-01 2016-12-31 0001518621 us-gaap:DividendDeclaredMember 2017-02-23 2017-08-01 0001518621 us-gaap:DividendDeclaredMember 2018-01-01 2018-12-31 0001518621 us-gaap:PerformanceSharesMember 2021-09-30 0001518621 2021-09-30 0001518621 2021-01-01 2021-03-31 0001518621 us-gaap:InterestRateSwapMember 2022-09-30 0001518621 us-gaap:DividendDeclaredMember 2019-01-01 2019-12-31 0001518621 us-gaap:InterestRateSwapMember orc:ThreeToFiveYearsMember 2022-09-30 0001518621 us-gaap:InterestRateSwapMember orc:ThreeToFiveYearsMember 2022-01-01 2022-09-30 0001518621 us-gaap:InterestRateSwapMember 2022-01-01 2022-09-30 0001518621 us-gaap:InterestRateSwapMember 2020-01-01 2020-12-31 0001518621 us-gaap:ResidentialMortgageBackedSecuritiesMember orc:PassThroughCertificateMemberMember 2021-12-31 0001518621 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:StructuredFinanceMember 2021-12-31 0001518621 2022-10-28 0001518621 us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-01-01 2022-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember 2022-07-01 2022-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember 2021-07-01 2021-09-30 0001518621 us-gaap:FairValueInputsLevel1Member 2022-09-30 0001518621 us-gaap:FairValueInputsLevel2Member 2022-09-30 0001518621 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001518621 us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateSwapMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateSwapMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateSwaptionMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwaptionMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateSwaptionMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001518621 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001518621 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001518621 us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateSwapMember 2021-12-31 0001518621 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember 2021-12-31 0001518621 us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateSwapMember 2021-12-31 0001518621 us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateSwaptionMember 2021-12-31 0001518621 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwaptionMember 2021-12-31 0001518621 us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateSwaptionMember 2021-12-31 0001518621 us-gaap:FairValueInputsLevel1Member orc:TbaContractsMember 2021-12-31 0001518621 us-gaap:FairValueInputsLevel2Member orc:TbaContractsMember 2021-12-31 0001518621 us-gaap:FairValueInputsLevel3Member orc:TbaContractsMember 2021-12-31 0001518621 us-gaap:InterestRateSwapMember orc:MoreThanFiveYearsMember 2022-09-30 0001518621 us-gaap:InterestRateSwapMember orc:MoreThanFiveYearsMember 2022-01-01 2022-09-30 0001518621 us-gaap:LongMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember orc:PayerSwaptionMember 2022-09-30 0001518621 us-gaap:LongMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember orc:PayerSwaptionMember 2021-12-31 0001518621 us-gaap:DerivativeMember us-gaap:ResidentialMortgageBackedSecuritiesMember orc:PassThroughCertificateMemberMember 2021-12-31 0001518621 us-gaap:DerivativeMember us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:StructuredFinanceMember 2021-12-31 0001518621 us-gaap:CashMember orc:DerivativeAgreementsMember 2022-09-30 0001518621 srt:MaximumMember orc:AtTheMarketOfferingProgramMember 2020-08-04 2021-06-21 0001518621 orc:AtTheMarketOfferingProgramMember 2020-08-04 2021-06-21 0001518621 us-gaap:RepurchaseAgreementsMember us-gaap:ResidentialMortgageBackedSecuritiesMember orc:PassThroughCertificateMemberMember 2022-09-30 0001518621 us-gaap:DerivativeMember us-gaap:ResidentialMortgageBackedSecuritiesMember orc:PassThroughCertificateMemberMember 2022-09-30 0001518621 us-gaap:ResidentialMortgageBackedSecuritiesMember orc:PassThroughCertificateMemberMember 2022-09-30 0001518621 us-gaap:RepurchaseAgreementsMember us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:StructuredFinanceMember 2022-09-30 0001518621 us-gaap:DerivativeMember us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:StructuredFinanceMember 2022-09-30 0001518621 us-gaap:ResidentialMortgageBackedSecuritiesMember us-gaap:StructuredFinanceMember 2022-09-30 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember 2022-09-30 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember 2021-12-31 0001518621 us-gaap:InterestRateSwapMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember 2022-09-30 0001518621 us-gaap:InterestRateSwapMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember 2021-12-31 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:ShortMember orc:PayerSwaptionMember 2022-09-30 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember us-gaap:ShortMember orc:PayerSwaptionMember 2021-12-31 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember orc:TbaContractsMember 2022-09-30 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember orc:TbaContractsMember 2021-12-31 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember orc:EurodollarFutureMarginMember 2022-09-30 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember orc:PayerSwaptionMember 2022-09-30 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember orc:EurodollarFutureMarginMember 2021-12-31 0001518621 us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember orc:PayerSwaptionMember 2021-12-31 0001518621 us-gaap:InterestRateSwapMember 2022-07-01 2022-09-30 0001518621 us-gaap:InterestRateSwapMember 2021-07-01 2021-09-30 0001518621 us-gaap:ShortMember orc:PayerSwaptionMember 2022-07-01 2022-09-30 0001518621 us-gaap:ShortMember orc:PayerSwaptionMember 2021-07-01 2021-09-30 0001518621 us-gaap:ShortMember orc:PayerSwaptionMember orc:LessThanOrEqualToOneYearMember 2022-01-01 2022-09-30 0001518621 us-gaap:ShortMember orc:PayerSwaptionMember orc:LessThanOrEqualToOneYearMember 2022-09-30 0001518621 us-gaap:OverAllotmentOptionMember 2021-01-21 2021-01-25 0001518621 orc:FollowOnOfferingMember 2021-01-21 2021-01-25 0001518621 orc:FollowOnOfferingMember 2021-01-25 0001518621 us-gaap:OverAllotmentOptionMember 2021-03-03 2021-03-05 0001518621 orc:FollowOnOfferingMember 2021-03-03 2021-03-05 0001518621 orc:FollowOnOfferingMember 2021-03-05 0001518621 2022-01-01 2022-03-31 0001518621 us-gaap:InterestRateSwapMember orc:ThreeToFiveYearsMember 2021-12-31 0001518621 us-gaap:InterestRateSwapMember orc:MoreThanFiveYearsMember 2021-12-31 0001518621 us-gaap:InterestRateSwapMember orc:ThreeToFiveYearsMember 2020-01-01 2020-12-31 0001518621 us-gaap:InterestRateSwapMember orc:MoreThanFiveYearsMember 2020-01-01 2020-12-31 0001518621 us-gaap:LongMember orc:PayerSwaptionMember orc:LessThanOrEqualToOneYearMember 2021-12-31 0001518621 us-gaap:LongMember orc:PayerSwaptionMember orc:OneYearToTwoYearsMember 2021-12-31 0001518621 us-gaap:LongMember orc:PayerSwaptionMember 2021-12-31 0001518621 us-gaap:ShortMember orc:PayerSwaptionMember orc:LessThanOrEqualToOneYearMember 2021-12-31 0001518621 us-gaap:LongMember orc:PayerSwaptionMember orc:LessThanOrEqualToOneYearMember 2021-01-01 2021-12-31 0001518621 us-gaap:LongMember orc:PayerSwaptionMember orc:OneYearToTwoYearsMember 2021-01-01 2021-12-31 0001518621 us-gaap:LongMember orc:PayerSwaptionMember 2021-01-01 2021-12-31 0001518621 us-gaap:ShortMember orc:PayerSwaptionMember orc:LessThanOrEqualToOneYearMember 2021-01-01 2021-12-31 0001518621 us-gaap:InterestRateFloorMember 2022-07-01 2022-09-30 0001518621 us-gaap:InterestRateFloorMember 2021-07-01 2021-09-30 0001518621 us-gaap:ShortMember orc:TbaContractsMember 2022-07-01 2022-09-30 0001518621 us-gaap:LongMember orc:TbaContractsMember 2022-07-01 2022-09-30 0001518621 us-gaap:ShortMember orc:TbaContractsMember 2021-07-01 2021-09-30 0001518621 us-gaap:LongMember orc:TbaContractsMember 2021-07-01 2021-09-30 0001518621 us-gaap:RepurchaseAgreementsMember 2022-09-30 0001518621 orc:DerivativeAgreementsMember 2022-09-30 0001518621 us-gaap:CashMember us-gaap:RepurchaseAgreementsMember 2021-12-31 0001518621 us-gaap:CashMember orc:DerivativeAgreementsMember 2021-12-31 0001518621 us-gaap:CashMember 2021-12-31 0001518621 us-gaap:RepurchaseAgreementsMember 2021-12-31 0001518621 orc:DerivativeAgreementsMember 2021-12-31 0001518621 orc:PayerSwaptionMember 2021-12-31 0001518621 us-gaap:CommonStockMember orc:ShareRepurchaseProgramMember 2015-07-29 2022-09-30 0001518621 us-gaap:CommonStockMember srt:MaximumMember orc:ShareRepurchaseProgramMember 2018-02-08 0001518621 us-gaap:DividendDeclaredMember 2017-01-01 2017-12-31 0001518621 us-gaap:DividendDeclaredMember 2020-01-01 2020-12-31 0001518621 us-gaap:DividendDeclaredMember us-gaap:SubsequentEventMember 2022-10-28 2022-10-28 0001518621 orc:ShareAwardsMember 2022-01-01 2022-09-30 0001518621 orc:ShareAwardsMember 2021-01-01 2021-09-30 0001518621 orc:DeferredStockUnitsMember 2021-12-31 0001518621 orc:DeferredStockUnitsMember 2022-01-01 2022-09-30 0001518621 orc:DeferredStockUnitsMember 2022-09-30 0001518621 orc:DeferredStockUnitsMember 2020-12-31 0001518621 orc:DeferredStockUnitsMember 2021-01-01 2021-09-30 0001518621 orc:DeferredStockUnitsMember 2021-09-30 0001518621 orc:BiminiAdvisorsLlcMember 2022-01-01 2022-09-30 0001518621 orc:BiminiAdvisorsLlcMember 2022-09-30 0001518621 orc:BiminiAdvisorsLlcMember 2021-12-31 0001518621 orc:BiminiCapitalManagementIncMember 2022-09-30 0001518621 us-gaap:CommonStockMember 2020-12-31 0001518621 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001518621 us-gaap:RetainedEarningsMember 2020-12-31 0001518621 us-gaap:CommonStockMember 2021-12-31 0001518621 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001518621 us-gaap:RetainedEarningsMember 2021-12-31 0001518621 us-gaap:CommonStockMember 2022-09-30 0001518621 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001518621 us-gaap:RetainedEarningsMember 2022-09-30 0001518621 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001518621 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001518621 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001518621 us-gaap:CommonStockMember 2021-03-31 0001518621 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001518621 us-gaap:RetainedEarningsMember 2021-03-31 0001518621 2021-03-31 0001518621 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001518621 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001518621 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001518621 srt:MaximumMember orc:AtTheMarketOfferingProgramMember 2021-06-22 2021-10-28 0001518621 orc:FixedRateMortgagesMember orc:PassThroughCertificateMemberMember 2022-09-30 0001518621 orc:FixedRateMortgagesMember orc:PassThroughCertificateMemberMember 2021-12-31 0001518621 orc:PassThroughCertificateMemberMember 2022-09-30 0001518621 orc:PassThroughCertificateMemberMember 2021-12-31 0001518621 us-gaap:StructuredFinanceMember orc:InterestOnlySecuritiesMember 2022-09-30 0001518621 us-gaap:StructuredFinanceMember orc:InterestOnlySecuritiesMember 2021-12-31 0001518621 us-gaap:StructuredFinanceMember orc:InverseInterestOnlyMember 2022-09-30 0001518621 us-gaap:StructuredFinanceMember orc:InverseInterestOnlyMember 2021-12-31 0001518621 us-gaap:StructuredFinanceMember 2022-09-30 0001518621 us-gaap:StructuredFinanceMember 2021-12-31 0001518621 us-gaap:ShortMember orc:FirstYearExpirationMember orc:TenYearUltraFuturesMember 2022-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember orc:LessThanOrEqualToOneYearMember 2022-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember orc:OneYearToTwoYearsMember 2022-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember 2022-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember orc:LessThanOrEqualToOneYearMember 2022-01-01 2022-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember orc:OneYearToTwoYearsMember 2022-01-01 2022-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember 2022-01-01 2022-09-30 0001518621 us-gaap:DerivativeMember 2021-12-31 0001518621 us-gaap:DerivativeMember 2022-09-30 0001518621 us-gaap:RepurchaseAgreementsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-09-30 0001518621 us-gaap:RepurchaseAgreementsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-12-31 0001518621 us-gaap:USTreasuryNotesSecuritiesMember 2022-09-30 0001518621 us-gaap:USTreasuryNotesSecuritiesMember 2021-12-31 0001518621 us-gaap:MortgageBackedSecuritiesMember 2022-09-30 0001518621 us-gaap:MortgageBackedSecuritiesMember 2021-12-31 0001518621 us-gaap:MaturityOvernightMember 2022-09-30 0001518621 us-gaap:MaturityUpTo30DaysMember 2022-09-30 0001518621 us-gaap:Maturity30To90DaysMember 2022-09-30 0001518621 us-gaap:MaturityOver90DaysMember 2022-09-30 0001518621 us-gaap:MaturityOvernightMember 2021-12-31 0001518621 us-gaap:MaturityUpTo30DaysMember 2021-12-31 0001518621 us-gaap:Maturity30To90DaysMember 2021-12-31 0001518621 us-gaap:MaturityOver90DaysMember 2021-12-31 0001518621 orc:FirmOfferingMember 2021-01-21 2021-01-25 0001518621 orc:FirmOfferingMember 2021-03-03 2021-03-05 0001518621 orc:AtTheMarketOfferingProgramMember 2021-06-22 2021-10-28 0001518621 srt:MaximumMember orc:AtTheMarketOfferingProgramMember 2021-10-29 2022-09-30 0001518621 orc:AtTheMarketOfferingProgramMember 2021-10-29 2022-09-30 0001518621 us-gaap:ShortMember orc:FirstYearExpirationMember orc:FiveYearTreasuryNoteFuturesMemberMember 2022-09-30 0001518621 us-gaap:ShortMember orc:FirstYearExpirationMember orc:FiveYearTreasuryNoteFuturesMemberMember 2021-12-31 0001518621 us-gaap:ShortMember orc:FirstYearExpirationMember orc:TenYearUltraFuturesMember 2021-12-31 0001518621 us-gaap:EurodollarFutureMember us-gaap:ShortMember 2022-07-01 2022-09-30 0001518621 us-gaap:EurodollarFutureMember us-gaap:ShortMember 2021-07-01 2021-09-30 0001518621 us-gaap:ShortMember orc:TreasuryNoteFutureMember 2022-07-01 2022-09-30 0001518621 us-gaap:ShortMember orc:TreasuryNoteFutureMember 2021-07-01 2021-09-30 0001518621 us-gaap:InterestRateCapMember us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember 2022-09-30 0001518621 us-gaap:InterestRateCapMember 2021-12-31 0001518621 us-gaap:InterestRateCapMember orc:TenYearVsTwoYearMember 2022-09-30 0001518621 us-gaap:InterestRateCapMember 2022-07-01 2022-09-30 0001518621 us-gaap:InterestRateCapMember 2021-07-01 2021-09-30 0001518621 us-gaap:DerivativeMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-09-30 0001518621 us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-09-30 0001518621 us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-12-31 0001518621 us-gaap:DerivativeMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-12-31 0001518621 us-gaap:RepurchaseAgreementsMember us-gaap:USTreasuryNotesSecuritiesMember 2022-09-30 0001518621 us-gaap:DerivativeMember us-gaap:USTreasuryNotesSecuritiesMember 2022-09-30 0001518621 us-gaap:USTreasuryNotesSecuritiesMember 2022-09-30 0001518621 us-gaap:RepurchaseAgreementsMember us-gaap:USTreasuryNotesSecuritiesMember 2021-12-31 0001518621 us-gaap:DerivativeMember us-gaap:USTreasuryNotesSecuritiesMember 2021-12-31 0001518621 us-gaap:USTreasuryNotesSecuritiesMember 2021-12-31 0001518621 us-gaap:InterestRateCapMember 2022-09-30 0001518621 orc:AtTheMarketOfferingProgramMember 2021-07-01 2021-09-30 0001518621 orc:AtTheMarketOfferingProgramMember 2021-10-01 2021-12-31 0001518621 orc:FollowOnOfferingMember 2021-01-01 2021-03-31 0001518621 2021-01-01 2021-12-31 0001518621 orc:AtTheMarketOfferingProgramMember 2021-09-30 0001518621 orc:FollowOnOfferingMember 2021-03-31 0001518621 orc:AtTheMarketOfferingProgramMember 2021-12-31 0001518621 us-gaap:DividendDeclaredMember 2021-01-01 2021-12-31 0001518621 us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateCapMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateCapMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel3Member us-gaap:InterestRateCapMember 2022-09-30 0001518621 orc:BiminiAdvisorsLlcMember 2022-07-01 2022-09-30 0001518621 us-gaap:ShortMember orc:ThirtyYearMember 2021-12-31 0001518621 us-gaap:CommonStockMember srt:MaximumMember orc:ShareRepurchaseProgramMember 2015-07-29 0001518621 us-gaap:CommonStockMember srt:MaximumMember orc:ProgramIncreaseOneMember 2018-02-08 0001518621 us-gaap:CommonStockMember srt:MaximumMember orc:ProgramIncreaseTwoMember 2021-12-09 0001518621 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001518621 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001518621 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001518621 2021-04-01 2021-06-30 0001518621 2021-06-30 0001518621 us-gaap:CommonStockMember 2021-06-30 0001518621 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001518621 us-gaap:RetainedEarningsMember 2021-06-30 0001518621 us-gaap:CommonStockMember 2022-03-31 0001518621 2022-03-31 0001518621 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001518621 us-gaap:RetainedEarningsMember 2022-03-31 0001518621 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001518621 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001518621 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001518621 2022-04-01 2022-06-30 0001518621 orc:AtTheMarketOfferingProgramMember 2021-01-01 2021-03-31 0001518621 orc:AtTheMarketOfferingProgramMember 2021-03-31 0001518621 us-gaap:ShortMember orc:TreasuryNoteFutureMember 2022-01-01 2022-09-30 0001518621 us-gaap:ShortMember orc:TreasuryNoteFutureMember 2021-01-01 2021-09-30 0001518621 us-gaap:EurodollarFutureMember us-gaap:ShortMember 2022-01-01 2022-09-30 0001518621 us-gaap:EurodollarFutureMember us-gaap:ShortMember 2021-01-01 2021-09-30 0001518621 us-gaap:InterestRateSwapMember 2021-01-01 2021-09-30 0001518621 us-gaap:ShortMember orc:PayerSwaptionMember 2022-01-01 2022-09-30 0001518621 us-gaap:ShortMember orc:PayerSwaptionMember 2021-01-01 2021-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember 2022-01-01 2022-09-30 0001518621 us-gaap:LongMember orc:PayerSwaptionMember 2021-01-01 2021-09-30 0001518621 us-gaap:InterestRateFloorMember 2022-01-01 2022-09-30 0001518621 us-gaap:InterestRateFloorMember 2021-01-01 2021-09-30 0001518621 us-gaap:InterestRateCapMember 2022-01-01 2022-09-30 0001518621 us-gaap:InterestRateCapMember 2021-01-01 2021-09-30 0001518621 us-gaap:ShortMember orc:TbaContractsMember 2022-01-01 2022-09-30 0001518621 us-gaap:ShortMember orc:TbaContractsMember 2021-01-01 2021-09-30 0001518621 us-gaap:LongMember orc:TbaContractsMember 2022-01-01 2022-09-30 0001518621 us-gaap:LongMember orc:TbaContractsMember 2021-01-01 2021-09-30 0001518621 us-gaap:ShortMember orc:ThirtyYearMember orc:TwopercentMember 2022-09-30 0001518621 orc:TbaContractsMember 2022-09-30 0001518621 orc:ToBeAnnouncedSecuritiesMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel1Member orc:TbaContractsMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel2Member orc:TbaContractsMember 2022-09-30 0001518621 us-gaap:FairValueInputsLevel3Member orc:TbaContractsMember 2022-09-30 0001518621 orc:BiminiAdvisorsLlcMember 2021-07-01 2021-09-30 0001518621 orc:BiminiAdvisorsLlcMember 2021-01-01 2021-09-30 0001518621 orc:ThirtyYearMember us-gaap:ShortMember orc:ThreePercentMemberMember 2021-12-31 0001518621 us-gaap:CommonStockMember orc:ShareRepurchaseProgramMember 2022-01-01 2022-09-30 0001518621 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001518621 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001518621 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001518621 2022-06-30 0001518621 us-gaap:CommonStockMember 2022-06-30 0001518621 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001518621 us-gaap:RetainedEarningsMember 2022-06-30 0001518621 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001518621 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001518621 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001518621 orc:AtTheMarketOfferingProgramMember 2021-04-01 2021-06-30 0001518621 orc:AtTheMarketOfferingProgramMember 2021-06-30 0001518621 us-gaap:ShortMember orc:ThirtyYearMember 2022-09-30 0001518621 us-gaap:ShortMember orc:ThirtyYearMember orc:ThreePercentMemberMember 2022-09-30 0001518621 srt:MaximumMember us-gaap:CommonStockMember orc:ShareRepurchaseProgramMember 2022-10-28 0001518621 us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-09-30 0001518621 srt:MaximumMember us-gaap:CommonStockMember orc:ProgramIncreaseThreeMember 2022-10-12 0001518621 srt:MaximumMember us-gaap:CommonStockMember orc:ShareRepurchaseProgramMember 2022-10-28 2022-10-28 iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares
 
 
 
 
 
 
 
 
 
 
 
orc10q20220930p1i0
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
☒
QUARTERLY
 
REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30, 2022
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to ___________
Commission File Number
:
 
001-35236
Orchid Island Capital, Inc.
(Exact name of registrant as specified in its charter)
Maryland
27-3269228
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
3305 Flamingo Drive
,
Vero Beach
,
Florida
32963
(Address of principal executive offices) (Zip Code)
 
(
772
)
231-1400
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol:
Name of Each Exchange on Which
Registered
Common Stock, $0.01 par value
ORC
New York Stock Exchange
Indicate by
 
check mark
 
whether the
 
registrant (1) has
 
filed all
 
reports required
 
to be
 
filed by
 
Section 13 or
 
15(d) of
 
the Securities
 
Exchange Act
 
of
1934 during the preceding 12 months (or for such shorter
 
period that the registrant was required to file such
 
reports), and (2) has been subject to such
filing requirements for the past 90 days.
 
Yes
☒
 
No
☐
Indicate by check
 
mark whether the registrant
 
has submitted electronically every
 
Interactive Data File required
 
to be submitted pursuant
 
to Rule 405
of Regulation S-T (§232.405 of this chapter) during the preceding 12
 
months (or for such shorter period that the registrant was
 
required to submit such
files).
 
Yes
☒
 
No
☐
Indicate by check mark whether the registrant is
 
a large accelerated filer,
 
an accelerated filer, a non-accelerated filer,
 
a smaller reporting company,
 
or
an emerging growth company. See the definitions of "large accelerated filer,"
 
"accelerated filer", "smaller reporting company", and "emerging growth
company" in Rule 12b-2 of the Exchange Act. Check one:
Large accelerated filer
☐
Accelerated filer
☒
Non-accelerated filer
☐
Smaller reporting company
☐
 
 
Emerging growth company
☐
If an emerging growth company,
 
indicate by check mark if the registrant has
 
elected not to use the extended transition period
 
for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
 
Yes
☐
 
No
☒
Number of shares outstanding at October 27, 2022:
33,422,207
ORCHID ISLAND
 
CAPITAL, INC.
TABLE OF CONTENTS
PART I. FINANCIAL
 
INFORMATION
ITEM 1. Financial
 
Statements
1
Condensed
 
Balance Sheets
 
(unaudited)
1
Condensed
 
Statements
 
of Operations
 
(unaudited)
2
Condensed
 
Statements
 
of Stockholders’
 
Equity (unaudited)
3
Condensed
 
Statements
 
of Cash Flows
 
(unaudited)
4
Notes to
 
Condensed
 
Financial
 
Statements
 
(unaudited)
5
ITEM 2. Management’s
 
Discussion
 
and Analysis
 
of Financial
 
Condition
 
and Results
 
of Operations
26
ITEM 3. Quantitative
 
and Qualitative
 
Disclosures
 
about Market
 
Risk
50
ITEM 4. Controls
 
and Procedures
54
PART II. OTHER INFORMATION
ITEM 1. Legal
 
Proceedings
55
ITEM 1A.
 
Risk Factors
55
ITEM 2. Unregistered
 
Sales of Equity
 
Securities
 
and Use of
 
Proceeds
55
ITEM 3. Defaults
 
upon Senior
 
Securities
55
ITEM 4. Mine
 
Safety Disclosures
55
ITEM 5. Other
 
Information
55
ITEM 6. Exhibits
56
SIGNATURES
57
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
PART I. FINANCIAL
 
INFORMATION
ITEM 1. FINANCIAL STATEMENTS
ORCHID ISLAND CAPITAL, INC.
CONDENSED BALANCE SHEETS
($ in thousands, except per share data)
(Unaudited)
September 30,
December 31,
2022
2021
ASSETS:
Mortgage-backed securities, at fair value (includes pledged assets
 
of $
3,195,846
and $
6,506,372
, respectively)
$
3,201,214
$
6,511,095
U.S. Treasury Notes, at fair value (includes pledged assets of $
36,118
 
and $
29,740
, respectively)
36,118
37,175
Cash and cash equivalents
214,183
385,143
Restricted cash
66,769
65,299
Accrued interest receivable
10,527
18,859
Derivative assets
262,318
50,786
Receivable for securities sold, pledged to counterparties
13,684
-
Other assets
1,027
320
Total Assets
$
3,805,840
$
7,068,677
LIABILITIES AND STOCKHOLDERS' EQUITY
LIABILITIES:
Repurchase agreements
$
3,133,861
$
6,244,106
Dividends payable
5,636
11,530
Derivative liabilities
53,013
7,589
Accrued interest payable
4,424
788
Due to affiliates
1,075
1,062
Other liabilities
207,454
35,505
Total Liabilities
3,405,463
6,300,580
 
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Preferred stock, $
0.01
 
par value;
20,000,000
 
shares authorized; no shares issued
and outstanding as of September 30, 2022 and December 31, 2021
-
-
Common Stock, $
0.01
 
par value;
100,000,000
 
shares authorized,
35,066,251
shares issued and outstanding as of September 30, 2022 and
35,398,610
 
shares issued
and outstanding as of December 31, 2021
351
354
Additional paid-in capital
776,159
850,497
Accumulated deficit
(376,133)
(82,754)
Total Stockholders' Equity
400,377
768,097
Total Liabilities
 
and Stockholders' Equity
$
3,805,840
$
7,068,677
See Notes to Financial Statements
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
ORCHID ISLAND CAPITAL, INC.
CONDENSED STATEMENTS
 
OF OPERATIONS
(Unaudited)
For the Three and Nine Months Ended September 30, 2022 and 2021
($ in thousands, except per share data)
Nine Months Ended September 30,
Three Months Ended September 30,
2022
2021
2022
2021
Interest income
$
112,735
$
90,279
$
35,610
$
34,169
Interest expense
(32,196)
(5,067)
(21,361)
(1,570)
Net interest income
80,539
85,212
14,249
32,599
Realized (losses) gains on mortgage-backed securities
(132,672)
(3,068)
(66,143)
2,977
Unrealized (losses) gains on mortgage-backed securities and
U.S. Treasury Notes
(692,781)
(107,386)
(212,221)
(11,239)
Gains on derivative and other hedging instruments
466,394
15,932
184,820
5,375
Net portfolio (loss) income
(278,520)
(9,310)
(79,295)
29,712
Expenses:
Management fees
7,881
5,569
2,616
2,156
Allocated overhead
1,482
1,189
522
390
Incentive compensation
763
884
212
259
Directors' fees and liability insurance
929
874
308
279
Audit, legal and other professional fees
899
832
293
212
Direct REIT operating expenses
2,281
1,024
1,064
309
Other administrative
624
514
203
69
Total expenses
14,859
10,886
5,218
3,674
Net (loss) income
$
(293,379)
$
(20,196)
$
(84,513)
$
26,038
Basic and diluted net (loss) income per share
$
(8.31)
$
(0.95)
$
(2.40)
$
1.00
Weighted Average Shares Outstanding
35,336,702
21,061,154
35,205,888
25,717,469
Dividends declared per common share
$
1.995
$
2.925
$
0.545
$
0.975
See Notes to Financial Statements
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3
ORCHID ISLAND CAPITAL, INC.
CONDENSED STATEMENTS
 
OF STOCKHOLDERS' EQUITY
(Unaudited)
For the Nine Months Ended September 30, 2022 and 2021
(in thousands)
Additional
Retained
Common Stock
Paid-in
Earnings
Shares
Par Value
Capital
(Deficit)
Total
Balances, January 1, 2021
15,215
$
152
$
433,133
$
(17,994)
$
415,291
Net loss
-
-
-
(29,369)
(29,369)
Cash dividends declared
-
-
(17,226)
-
(17,226)
Issuance of common stock pursuant to public offerings, net
3,650
37
96,871
-
96,908
Stock based awards and amortization
18
-
572
-
572
Balances, March 31, 2021
18,883
$
189
$
513,350
$
(47,363)
$
466,176
Net income
-
-
-
(16,865)
(16,865)
Cash dividends declared
-
-
(20,416)
-
(20,416)
Issuance of common stock pursuant to public offerings, net
4,617
46
124,700
-
124,746
Stock based awards and amortization
-
-
180
-
180
Balances, June 30, 2021
23,500
$
235
$
617,814
$
(64,228)
$
553,821
Net income
-
-
-
26,038
26,038
Cash dividends declared
-
-
(26,420)
-
(26,420)
Issuance of common stock pursuant to public offerings, net
7,164
71
176,936
-
177,007
Stock based awards and amortization
-
-
183
-
183
Balances, September 30, 2021
30,664
$
306
$
768,513
$
(38,190)
$
730,629
Balances, January 1, 2022
35,399
$
354
$
850,497
$
(82,754)
$
768,097
Net loss
-
-
-
(148,727)
(148,727)
Cash dividends declared
-
-
(27,492)
-
(27,492)
Stock based awards and amortization
25
-
540
-
540
Balances, March 31, 2022
35,424
$
354
$
823,545
$
(231,481)
$
592,418
Net loss
-
-
-
(60,139)
(60,139)
Cash dividends declared
-
-
(23,936)
-
(23,936)
Stock based awards and amortization
2
-
237
-
237
Shares repurchased and retired
(175)
(1)
(2,217)
-
(2,218)
Balances, June 30, 2022
35,251
$
353
$
797,629
$
(291,620)
$
506,362
Net income
-
-
-
(84,513)
(84,513)
Cash dividends declared
-
-
(19,231)
-
(19,231)
Stock based awards and amortization
1
-
143
-
143
Shares repurchased and retired
(186)
(2)
(2,382)
-
(2,384)
Balances, September 30, 2022
35,066
$
351
$
776,159
$
(376,133)
$
400,377
See Notes to Financial Statements
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4
ORCHID ISLAND CAPITAL, INC.
CONDENSED STATEMENTS
 
OF CASH FLOWS
(Unaudited)
For the Nine Months Ended September 30, 2022 and 2021
($ in thousands)
2022
2021
CASH FLOWS FROM OPERATING
 
ACTIVITIES:
Net loss
$
(293,379)
$
(20,196)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock based compensation
552
612
Realized losses on mortgage-backed securities
132,672
3,068
Unrealized losses on mortgage-backed securities and U.S. Treasury
 
Notes
692,781
107,386
Realized and unrealized gains on derivative instruments
(261,364)
(22,180)
Changes in operating assets and liabilities:
Accrued interest receivable
8,332
(5,449)
Other assets
(353)
74
Accrued interest payable
3,636
(404)
Other liabilities
7,770
(2,031)
Due to affiliates
13
303
NET CASH PROVIDED BY OPERATING
 
ACTIVITIES
290,660
61,183
CASH FLOWS FROM INVESTING ACTIVITIES:
From mortgage-backed securities investments:
Purchases
(622,535)
(4,816,301)
Sales
2,731,497
2,598,893
Principal repayments
376,169
413,005
Purchases of U.S. Treasury Notes
-
(37,440)
Net proceeds from (payments on) derivative instruments
246,321
(1,228)
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES
2,731,452
(1,843,071)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from repurchase agreements
32,427,448
22,995,280
Principal payments on repurchase agreements
(35,537,693)
(21,376,997)
Cash dividends
(76,527)
(59,019)
Proceeds from issuance of common stock, net of issuance costs
-
398,661
Shares repurchased and retired
(4,602)
-
Shares withheld from employee stock awards for payment of taxes
(228)
(299)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES
(3,191,602)
1,957,626
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS
 
AND RESTRICTED CASH
(169,490)
175,738
CASH, CASH EQUIVALENTS
 
AND RESTRICTED CASH, beginning of the period
450,442
299,506
CASH, CASH EQUIVALENTS
 
AND RESTRICTED CASH, end of the period
$
280,952
$
475,244
SUPPLEMENTAL DISCLOSURE OF
 
CASH FLOW INFORMATION:
Cash paid during the period for:
Interest
$
28,560
$
5,471
SUPPLEMENTAL DISCLOSURE OF
 
NONCASH INVESTING ACTIVITIES:
Securities acquired settled in later period
$
-
$
180,619
See Notes to Financial Statements
5
ORCHID ISLAND
 
CAPITAL, INC.
NOTES TO CONDENSED
 
FINANCIAL
 
STATEMENTS
(Unaudited)
SEPTEMBER
 
30, 2022
NOTE 1.
 
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES
Organization
 
and Business
 
Description
Orchid Island
 
Capital,
 
Inc. (“Orchid”
 
or the “Company”)
 
was incorporated
 
in Maryland
 
on August
 
17, 2010
 
for the purpose
 
of creating
and managing
 
a leveraged
 
investment
 
portfolio
 
consisting
 
of residential
 
mortgage-backed
 
securities
 
(“RMBS”).
 
From incorporation
 
to the
completion
 
of Orchid’s
 
initial public
 
offering of
 
its common
 
stock on
 
February
 
20, 2013,
 
Orchid was
 
a wholly
 
owned subsidiary
 
of Bimini
Capital Management,
 
Inc. (“Bimini”).
 
Orchid began
 
operations
 
on November
 
24, 2010
 
(the date
 
of commencement
 
of operations).
 
From
incorporation
 
through November
 
24, 2010,
 
Orchid’s only
 
activity
 
was the issuance
 
of common
 
stock to Bimini.
On August 4, 2020, Orchid entered into an equity distribution agreement (the “August
 
2020 Equity Distribution Agreement”) with
four sales agents pursuant to which the Company could offer and sell, from time to time,
 
up to an aggregate amount of $
150,000,000
 
of
shares of the Company’s common stock in transactions that were deemed to be “at the market” offerings and privately
 
negotiated
transactions.
 
The Company issued a total of
5,538,730
 
shares under the August 2020 Equity Distribution Agreement for aggregate
gross proceeds of
approximately $
150.0
 
million, and net proceeds of approximately $
147.4
 
million, after commissions and fees, prior to
its termination in June 2021.
On January 20, 2021, Orchid entered into an underwriting
 
agreement (the “January 2021 Underwriting Agreement”) with
 
J.P.
Morgan Securities LLC (“J.P. Morgan”), relating to the offer and sale of
1,520,000
 
shares of the Company’s common stock. J.P.
Morgan purchased the shares of the Company’s common stock from the Company pursuant
 
to the January 2021 Underwriting
Agreement at $
26.00
 
per share. In addition, the Company granted J.P. Morgan a 30-day option to purchase up to an additional
228,000
 
shares of the Company’s common stock on the same terms and conditions, which J.P. Morgan exercised in full on January 21,
2021. The closing of the offering of
1,748,000
 
shares of the Company’s common stock occurred on January 25, 2021, with proceeds to
the Company of approximately $
45.2
 
million, net of offering expenses.
On March 2, 2021, Orchid entered into an underwriting agreement (the “March 2021
 
Underwriting Agreement”) with J.P. Morgan,
relating to the offer and sale of
1,600,000
 
shares of the Company’s common stock. J.P. Morgan purchased the shares of the
Company’s common stock from the Company pursuant to the March 2021 Underwriting
 
Agreement at $
27.25
 
per share. In addition,
the Company granted J.P. Morgan a 30-day option to purchase up to an additional
240,000
 
shares of the Company’s common stock on
the same terms and conditions, which J.P. Morgan exercised in full on March 3, 2021. The closing of the offering of
1,840,000
 
shares
of the Company’s common stock occurred on March 5, 2021, with proceeds to the Company
 
of approximately $
50.0
 
million, net of
offering expenses.
On June 22, 2021, Orchid entered into an equity distribution agreement
 
(the “June 2021 Equity Distribution Agreement”) with four
sales agents pursuant to which the Company could offer and sell, from time to time, up to
 
an aggregate amount of $
250,000,000
 
of
shares of the Company’s common stock in transactions that were deemed to be “at the market” offerings and privately negotiated
transactions. The Company issued a total of
9,881,467
 
shares under the June 2021 Equity Distribution Agreement for aggregate gross
proceeds of approximately $
250.0
 
million, and net proceeds of approximately $
246.0
 
million, after commissions and fees, prior to its
termination in October 2021.
6
On October 29, 2021, Orchid entered into an equity distribution agreement (the
 
“October 2021 Equity Distribution Agreement”) with
four sales agents pursuant to which the Company may offer and sell, from time to time,
 
up to an aggregate amount of $
250,000,000
 
of
shares of the Company’s common stock in transactions that are deemed to be “at the market”
 
offerings and privately negotiated
transactions.
 
Through September 30, 2022, the Company issued a total of
3,167,140
 
shares under the October 2021 Equity
Distribution Agreement for aggregate gross proceeds of approximately $
78.3
 
million, and net proceeds of approximately $
77.0
 
million,
after commissions and fees. No shares were issued under the October 2021
 
Equity Distribution Agreement during the nine months
ended September 30, 2022.
Basis of
 
Presentation
 
and Use of
 
Estimates
The accompanying
 
unaudited
 
financial
 
statements
 
have been
 
prepared
 
in accordance
 
with accounting
 
principles
 
generally
 
accepted
in the United
 
States (“GAAP”)
 
for interim
 
financial
 
information
 
and with
 
the instructions
 
to Form 10-Q
 
and Article
 
8 of Regulation
 
S-X.
 
Accordingly, they
 
do not include
 
all of the
 
information
 
and footnotes
 
required
 
by GAAP for
 
complete financial
 
statements.
 
In the opinion
 
of
management,
 
all adjustments
 
(consisting
 
of normal
 
recurring
 
accruals)
 
considered
 
necessary
 
for a fair
 
presentation
 
have been
 
included.
 
Operating
 
results for
 
the nine and
 
three month
 
periods
 
ended September
 
30, 2022
 
are not necessarily
 
indicative
 
of the results
 
that may
 
be
expected for
 
the year
 
ending December
 
31, 2022.
The balance
 
sheet at December
 
31, 2021
 
has been
 
derived from
 
the audited
 
financial
 
statements
 
at that date
 
but does
 
not include
 
all
of the information
 
and footnotes
 
required
 
by GAAP for
 
complete financial
 
statements.
 
For further
 
information,
 
refer to
 
the financial
statements
 
and footnotes
 
thereto included
 
in the Company’s
 
Annual Report
 
on Form 10-K
 
for the year
 
ended December
 
31, 2021.
The preparation
 
of financial
 
statements
 
in conformity
 
with GAAP
 
requires
 
management
 
to make estimates
 
and assumptions
 
that affect
the reported
 
amounts of
 
assets and
 
liabilities
 
and disclosure
 
of contingent
 
assets and
 
liabilities
 
at the date
 
of the financial
 
statements
 
and
the reported
 
amounts of
 
revenues
 
and expenses
 
during the
 
reporting
 
period. Actual
 
results could
 
differ from
 
those estimates.
 
The
significant
 
estimates
 
affecting the
 
accompanying
 
financial
 
statements
 
are the fair
 
values of RMBS
 
and derivatives.
 
Management
 
believes
the estimates
 
and assumptions
 
underlying
 
the financial
 
statements
 
are reasonable
 
based on
 
the information
 
available as
 
of September
 
30,
2022.
Common Stock
 
Reverse
 
Split
On August 30, 2022, the Company effected a 1-for-5 reverse stock split of its common
 
stock and proportionately decreased the
number of authorized shares of common stock.
 
All share, per share, deferred stock unit (“DSU”) and performance unit (“PU”)
information has been retroactively adjusted to reflect the reverse split.
 
The shares of common stock retain a par value of $0.01 per
share.
Variable Interest Entities (“VIEs”)
The Company obtains interests in VIEs through its investments in mortgage-backed
 
securities.
 
The Company’s interests in these
VIEs are passive in nature and are not expected to result in the Company obtaining a
 
controlling financial interest in these VIEs in the
future.
 
As a result, the Company does not consolidate these VIEs and accounts
 
for these interests in these VIEs as mortgage-backed
securities.
 
See Note 2 for additional information regarding the Company’s investments in
 
mortgage-backed securities.
 
The maximum
exposure to loss for these VIEs is the carrying value of the mortgage-backed securities.
 
 
 
 
 
 
 
 
 
 
 
 
7
Cash and Cash Equivalents and Restricted Cash
Cash and
 
cash equivalents
 
include
 
cash on deposit
 
with financial
 
institutions
 
and highly
 
liquid investments
 
with original
 
maturities
 
of
three months
 
or less at
 
the time
 
of purchase.
 
Restricted
 
cash includes
 
cash pledged
 
as collateral
 
for repurchase
 
agreements
 
and other
borrowings,
 
and interest
 
rate swaps
 
and other
 
derivative
 
instruments.
The following
 
table provides
 
a reconciliation
 
of cash,
 
cash equivalents,
 
and restricted
 
cash reported
 
within the
 
statement
 
of financial
position that
 
sum to the
 
total of
 
the same such
 
amounts shown
 
in the statement
 
of cash flows.
(in thousands)
September 30, 2022
December 31, 2021
Cash and cash equivalents
$
214,183
$
385,143
Restricted cash
66,769
65,299
Total cash, cash equivalents
 
and restricted cash
$
280,952
$
450,442
The Company
 
maintains
 
cash balances
 
at three
 
banks and
 
excess margin
 
on account
 
with two
 
exchange clearing
 
members.
 
At times,
balances may
 
exceed federally
 
insured limits.
 
The Company
 
has not
 
experienced
 
any losses
 
related to
 
these balances.
 
The Federal
Deposit Insurance
 
Corporation
 
insures eligible
 
accounts
 
up to $250,000
 
per depositor
 
at each financial
 
institution.
 
Restricted
 
cash
balances are
 
uninsured,
 
but are held
 
in separate
 
customer accounts
 
that are
 
segregated
 
from the
 
general funds
 
of the counterparty.
 
The
Company limits
 
uninsured
 
balances
 
to only large,
 
well-known
 
banks and
 
exchange clearing
 
members and
 
believes that
 
it is not
 
exposed to
any significant
 
credit risk
 
on cash and
 
cash equivalents
 
or restricted
 
cash balances.
Mortgage-Backed
 
Securities
 
and U.S.
 
Treasury Notes
The Company
 
invests primarily
 
in mortgage
 
pass-through
 
(“PT”) residential
 
mortgage
 
backed securities
 
(“RMBS”)
 
and collateralized
mortgage
 
obligations
 
(“CMOs”)
 
issued by
 
Freddie Mac,
 
Fannie Mae
 
or Ginnie
 
Mae,
 
interest-only
 
(“IO”) securities
 
and inverse
 
interest-only
(“IIO”) securities
 
representing interest in or obligations backed by pools of RMBS. The Company
 
refers
 
to RMBS and CMOs as PT
RMBS. The Company refers to IO and IIO securities as structured RMBS. The Company
 
also invests in U.S. Treasury Notes, primarily
to satisfy collateral requirements of derivative counterparties. The Company has elected
 
to account for its investment in RMBS and
U.S. Treasury Notes
 
under the fair value option. Electing the fair value option requires the
 
Company to record changes in fair value in
the statement of operations, which, in management’s view, more appropriately reflects the results of the Company’s operations for a
particular reporting period and is consistent with the underlying economics and how the
 
portfolio is managed.
The Company
 
records securities
 
transactions
 
on the trade
 
date. Security
 
purchases
 
that have
 
not settled
 
as of the
 
balance sheet
 
date
are included
 
in the portfolio
 
balance with
 
an offsetting
 
liability
 
recorded,
 
whereas securities
 
sold that
 
have not
 
settled as
 
of the balance
sheet date
 
are removed
 
from the portfolio
 
balance with
 
an offsetting
 
receivable
 
recorded.
Fair value
 
is defined
 
as the price
 
that would
 
be received
 
to sell the
 
asset or
 
paid to transfer
 
the liability
 
in an orderly
 
transaction
between market
 
participants
 
at the measurement
 
date.
 
The fair
 
value measurement
 
assumes
 
that the
 
transaction
 
to sell the
 
asset or
transfer
 
the liability
 
either occurs
 
in the principal
 
market for
 
the asset
 
or liability, or
 
in the absence
 
of a principal
 
market, occurs
 
in the most
advantageous
 
market for
 
the asset
 
or liability. Estimated
 
fair values
 
for RMBS
 
are based
 
on independent
 
pricing sources
 
and/or third
 
party
broker quotes,
 
when available.
 
Estimated
 
fair values
 
for U.S.
 
Treasury Notes
 
are based
 
on quoted
 
prices for
 
identical
 
assets in
 
active
markets.
8
Income on
 
PT RMBS
 
and U.S. Treasury
 
Notes is based
 
on the stated
 
interest
 
rate of the
 
security. Premiums
 
or discounts
 
present
 
at
the date
 
of purchase
 
are not amortized.
 
Premium lost
 
and discount
 
accretion
 
resulting
 
from monthly
 
principal
 
repayments
 
are reflected
 
in
unrealized
 
gains (losses)
 
on RMBS
 
in the statements
 
of operations.
 
For IO securities,
 
the income
 
is accrued
 
based on
 
the carrying
 
value
and the effective
 
yield. The
 
difference
 
between income
 
accrued
 
and the interest
 
received on
 
the security
 
is characterized
 
as a return
 
of
investment
 
and serves
 
to reduce
 
the asset’s
 
carrying value.
 
At each
 
reporting
 
date, the
 
effective yield
 
is adjusted
 
prospectively
 
for future
reporting
 
periods
 
based on
 
the new estimate
 
of prepayments
 
and the contractual
 
terms of
 
the security. For
 
IIO securities,
 
effective
 
yield
and income
 
recognition
 
calculations
 
also take
 
into account
 
the index
 
value applicable
 
to the security.
 
Changes in
 
fair value
 
of RMBS during
each reporting
 
period are
 
recorded
 
in earnings
 
and reported
 
as unrealized
 
gains or
 
losses on
 
mortgage-backed
 
securities
 
in the
accompanying
 
statements
 
of operations.
Derivative and Other Hedging Instruments
 
The Company
 
uses derivative
 
and other
 
hedging instruments
 
to manage
 
interest
 
rate risk,
 
facilitate
 
asset/liability
 
strategies
 
and
manage other
 
exposures,
 
and it may
 
continue to
 
do so in the
 
future. The
 
principal
 
instruments
 
that the
 
Company has
 
used to date
 
are
Treasury Note
 
(“T-Note”),
 
federal funds
 
(“Fed Funds”)
 
and Eurodollar
 
futures contracts,
 
short positions
 
in U.S.
 
Treasury securities,
 
interest
rate swaps,
 
options to
 
enter in
 
interest
 
rate swaps
 
(“interest
 
rate swaptions”)
 
and “to-be-announced”
 
(“TBA”)
 
securities
 
transactions,
 
but the
Company may
 
enter into
 
other derivative
 
and other
 
hedging instruments
 
in the future.
 
The Company
 
accounts for
 
TBA securities
 
as derivative
 
instruments.
 
Gains and
 
losses associated
 
with TBA
 
securities
 
transactions
are reported
 
in gain (loss)
 
on derivative
 
instruments
 
in the accompanying
 
statements
 
of operations.
Derivative
 
and other
 
hedging instruments
 
are carried
 
at fair value,
 
and changes
 
in fair value
 
are recorded
 
in earnings
 
for each
 
period.
The Company’s
 
derivative
 
financial
 
instruments
 
are not designated
 
as hedge
 
accounting
 
relationships,
 
but rather
 
are used
 
as economic
hedges of
 
its portfolio
 
assets and
 
liabilities.
 
Gains and
 
losses on
 
derivatives,
 
except those
 
that result
 
in cash receipts
 
or payments,
 
are
included in
 
operating
 
activities
 
on the statement
 
of cash flows.
 
Cash payments
 
and cash receipts
 
from settlements
 
of derivatives,
 
including
current period
 
net cash settlements
 
on interest
 
rates swaps,
 
are classified
 
as an investing
 
activity
 
on the statements
 
of cash flows.
Holding derivatives
 
creates exposure
 
to credit
 
risk related
 
to the potential
 
for failure
 
on the part
 
of counterparties
 
and exchanges
 
to
honor their
 
commitments.
 
In the event
 
of default
 
by a counterparty,
 
the Company
 
may have
 
difficulty recovering
 
its collateral
 
and may not
receive
 
payments provided
 
for under
 
the terms
 
of the agreement.
 
The Company’s
 
derivative
 
agreements
 
require it
 
to post or
 
receive
collateral
 
to mitigate
 
such risk.
 
In addition,
 
the Company
 
uses only
 
registered
 
central clearing
 
exchanges
 
and well-established
 
commercial
banks as counterparties,
 
monitors
 
positions
 
with individual
 
counterparties
 
and adjusts
 
posted collateral
 
as required.
Financial
 
Instruments
The fair
 
value of financial
 
instruments
 
for which
 
it is practicable
 
to estimate
 
that value
 
is disclosed
 
either in
 
the body
 
of the financial
statements
 
or in the
 
accompanying
 
notes. RMBS,
 
Eurodollar,
 
Fed Funds
 
and T-Note futures
 
contracts,
 
interest
 
rate swaps,
 
interest
 
rate
swaptions
 
and TBA
 
securities
 
are accounted
 
for at fair
 
value in the
 
balance sheets.
 
The methods
 
and assumptions
 
used to
 
estimate fair
value for
 
these instruments
 
are presented
 
in Note 12
 
of the financial
 
statements.
The estimated
 
fair value
 
of cash and
 
cash equivalents,
 
restricted
 
cash, accrued
 
interest
 
receivable,
 
receivable
 
for securities
 
sold,
other assets,
 
due to affiliates,
 
repurchase
 
agreements,
 
payable for
 
unsettled
 
securities
 
purchased,
 
accrued interest
 
payable and
 
other
liabilities
 
generally
 
approximates
 
their carrying
 
values as
 
of September
 
30, 2022
 
and December
 
31, 2021 due
 
to the short-term
 
nature of
these financial
 
instruments.
 
9
Repurchase
 
Agreements
The Company
 
finances the
 
acquisition
 
of the majority
 
of its RMBS
 
through the
 
use of repurchase
 
agreements
 
under master
repurchase
 
agreements.
 
Repurchase
 
agreements
 
are accounted
 
for as collateralized
 
financing
 
transactions,
 
which are
 
carried at
 
their
contractual
 
amounts,
 
including
 
accrued interest,
 
as specified
 
in the respective
 
agreements.
Manager Compensation
The Company
 
is externally
 
managed
 
by Bimini
 
Advisors,
 
LLC (the
 
“Manager”
 
or “Bimini
 
Advisors”),
 
a Maryland
 
limited liability
company and
 
wholly-owned
 
subsidiary
 
of Bimini.
 
The Company’s
 
management
 
agreement
 
with the
 
Manager provides
 
for payment
 
to the
Manager of
 
a management
 
fee and reimbursement
 
of certain
 
operating
 
expenses,
 
which are
 
accrued and
 
expensed during
 
the period
 
for
which they
 
are earned
 
or incurred.
 
Refer to
 
Note 13 for
 
the terms
 
of the management
 
agreement.
Earnings
 
Per Share
Basic earnings
 
per share
 
(“EPS”)
 
is calculated
 
as net income
 
or loss attributable
 
to common
 
stockholders
 
divided by
 
the weighted
average number
 
of shares
 
of common
 
stock outstanding
 
during the
 
period. Diluted
 
EPS is calculated
 
using the
 
treasury
 
stock or
 
two-class
method, as
 
applicable,
 
for common
 
stock equivalents,
 
if any. However, the
 
common stock
 
equivalents
 
are not included
 
in computing
diluted EPS
 
if the result
 
is anti-dilutive.
 
Stock-Based
 
Compensation
The Company
 
may grant
 
equity-based
 
compensation
 
to non-employee
 
members of
 
its Board
 
of Directors
 
and to the
 
executive
 
officers
and employees
 
of the Manager.
 
Stock-based
 
awards issued
 
include performance
 
units, deferred
 
stock units
 
and immediately
 
vested
common stock
 
awards. Compensation
 
expense is
 
measured
 
and recognized
 
for all stock-based
 
payment awards
 
made to employees
 
and
non-employee
 
directors
 
based on
 
the fair
 
value of the
 
Company’s common
 
stock on
 
the date
 
of grant.
 
Compensation
 
expense is
recognized
 
over each
 
award’s respective
 
service period
 
using the
 
graded vesting
 
attribution
 
method. The
 
Company does
 
not estimate
forfeiture
 
rates; but
 
rather, adjusts
 
for forfeitures
 
in the periods
 
in which
 
they occur.
Income Taxes
Orchid has elected and is organized and operated so as to qualify to be taxed as a
 
real estate investment trust (“REIT”) under the
Internal Revenue Code of 1986, as amended (the “Code”).
 
REITs are generally not subject to federal income tax on their REIT taxable
income provided that they distribute to their stockholders all of their REIT taxable income
 
on an annual basis. A REIT must distribute at
least 90% of its REIT taxable income, determined without regard to the
 
deductions for dividends paid and excluding net capital gain,
and meet other requirements of the Code to retain its tax status.
Orchid assesses the likelihood, based on their technical merit, that uncertain tax
 
positions will be sustained upon examination
based on the facts, circumstances and information available at the end of each period.
 
All of Orchid’s tax positions are categorized as
highly certain.
 
There is no accrual for any tax, interest or penalties related to Orchid’s tax position
 
assessment.
 
The measurement of
uncertain tax positions is adjusted when new information is available,
 
or when an event occurs that requires a change.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10
Recent Accounting
 
Pronouncements
In March 2020, the FASB issued ASU 2020-04 “
Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate
Reform on Financial Reporting.
”
 
ASU 2020-04 provides optional expedients and exceptions to GAAP requirements
 
for modifications
on debt instruments, leases, derivatives, and other contracts, related to the expected
 
market transition from the London Interbank
Offered Rate (“LIBOR”), and certain other floating rate benchmark indices, or collectively, IBORs, to alternative reference rates. ASU
2020-04 generally considers contract modifications related to reference rate reform to
 
be an event that does not require contract
remeasurement at the modification date nor a reassessment of a previous accounting
 
determination. The guidance in ASU 2020-04 is
optional and may be elected over time, through December 31, 2022, as reference
 
rate reform activities occur. The Company does not
believe the adoption of this ASU will have a material impact on its financial statements.
In January 2021, the FASB issued ASU 2021-01 “
Reference Rate Reform (Topic 848
).” ASU 2021-01 expands the scope of ASC
848 to include all affected derivatives and give market participants the ability to apply certain
 
aspects of the contract modification and
hedge accounting expedients to derivative contracts affected by the discounting transition. In addition,
 
ASU 2021-01 adds
implementation guidance to permit a company to apply certain optional expedients
 
to modifications of interest rate indexes used for
margining, discounting or contract price alignment of certain derivatives as a result
 
of reference rate reform initiatives and extends
optional expedients to account for a derivative contract modified as a continuation
 
of the existing contract and to continue hedge
accounting when certain critical terms of a hedging relationship change to
 
modifications made as part of the discounting transition. The
guidance in ASU 2021-01 is effective
 
immediately and available generally through December 31, 2022, as reference
 
rate reform
activities occur. The Company does not believe the adoption of this ASU will have a material impact on its financial statements.
NOTE 2.
 
MORTGAGE-BACKED SECURITIES AND U.S. TREASURY NOTES
The following
 
table presents
 
the Company’s
 
RMBS portfolio
 
as of September
 
30, 2022
 
and December
 
31, 2021:
(in thousands)
September 30, 2022
December 31, 2021
Pass-Through RMBS Certificates:
Fixed-rate Mortgages
 
$
3,150,403
$
6,298,189
Total Pass-Through
 
Certificates
3,150,403
6,298,189
Structured RMBS Certificates:
Interest-Only Securities
50,274
210,382
Inverse Interest-Only Securities
537
2,524
Total Structured
 
RMBS Certificates
50,811
212,906
Total
$
3,201,214
$
6,511,095
As of September
 
30, 2022
 
and December
 
31, 2021,
 
the Company
 
held U.S.
 
Treasury Notes
 
with a fair
 
value of approximately
 
$
36.1
million and
 
$
37.2
 
million,
 
respectively, primarily
 
to satisfy
 
collateral
 
requirements
 
of one of
 
its derivative
 
counterparties.
The following
 
table is a
 
summary of
 
the Company’s
 
net gain
 
(loss) from
 
the sale of
 
RMBS for
 
the nine
 
months ended
 
September
 
30,
2022 and
 
2021.
Nine Months Ended September 30,
2022
2021
Proceeds from sales of RMBS
$
2,731,497
$
2,598,893
Carrying value of RMBS sold
(2,864,169)
(2,601,961)
Net (loss) gain on sales of RMBS
$
(132,672)
$
(3,068)
Gross gain on sales of RMBS
$
2,705
$
7,866
Gross loss on sales of RMBS
(135,377)
(10,934)
Net (loss) gain on sales of RMBS
$
(132,672)
$
(3,068)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11
NOTE 3.
 
REPURCHASE AGREEMENTS
The Company
 
pledges certain
 
of its RMBS
 
as collateral
 
under repurchase
 
agreements
 
with financial
 
institutions.
 
Interest
 
rates are
generally
 
fixed based
 
on prevailing
 
rates corresponding
 
to the terms
 
of the borrowings,
 
and interest
 
is generally
 
paid at the
 
termination
 
of a
borrowing.
 
If the fair
 
value of the
 
pledged securities
 
declines,
 
lenders
 
will typically
 
require the
 
Company to
 
post additional
 
collateral
 
or pay
down borrowings
 
to re-establish
 
agreed upon
 
collateral
 
requirements,
 
referred
 
to as "margin
 
calls." Similarly,
 
if the fair
 
value of
 
the pledged
securities
 
increases,
 
lenders
 
may release
 
collateral
 
back to the
 
Company. As of
 
September
 
30, 2022,
 
the Company
 
had met all
 
margin call
requirements.
As of September
 
30, 2022
 
and December
 
31, 2021,
 
the Company’s
 
repurchase
 
agreements
 
had remaining
 
maturities
 
as summarized
below:
($ in thousands)
OVERNIGHT
BETWEEN 2
BETWEEN 31
GREATER
 
(1 DAY OR
AND
AND
THAN
LESS)
30 DAYS
90 DAYS
90 DAYS
TOTAL
(1)
September 30, 2022
Fair market value of securities pledged, including
accrued interest receivable
$
-
$
1,731,976
$
1,413,061
$
61,316
$
3,206,353
Repurchase agreement liabilities associated with
these securities
$
-
$
1,707,215
$
1,372,870
$
53,776
$
3,133,861
Net weighted average borrowing rate
-
 
2.96%
3.07%
2.84%
3.00%
December 31, 2021
Fair market value of securities pledged, including
accrued interest receivable
$
-
$
4,624,396
$
1,848,080
$
52,699
$
6,525,175
Repurchase agreement liabilities associated with
these securities
$
-
$
4,403,182
$
1,789,327
$
51,597
$
6,244,106
Net weighted average borrowing rate
-
0.15%
0.13%
0.15%
0.15%
1)
Includes repurchase agreements with outstanding principal balances of approximately
 
$
103.7
 
million as of September 30, 2022, with interest
rates indexed to Secured Overnight Financing Rate (“SOFR”) that reprice daily.
In addition, cash pledged to counterparties for repurchase agreements was approximately
 
$
49.4
 
million and $
57.3
 
million as of
September 30, 2022 and December 31, 2021, respectively.
If, during
 
the term
 
of a repurchase
 
agreement,
 
a lender
 
files for
 
bankruptcy, the
 
Company might
 
experience
 
difficulty recovering
 
its
pledged assets,
 
which could
 
result in
 
an unsecured
 
claim against
 
the lender
 
for the difference
 
between the
 
amount loaned
 
to the Company
plus interest
 
due to the
 
counterparty
 
and the fair
 
value of the
 
collateral
 
pledged to
 
such lender,
 
including the accrued interest receivable
and cash posted by the Company as collateral. At September
 
30, 2022,
 
the Company
 
had an aggregate
 
amount at
 
risk (the
 
difference
between the
 
amount loaned
 
to the Company,
 
including
 
interest
 
payable and
 
securities
 
posted by
 
the counterparty
 
(if any),
 
and the fair
value of securities
 
and cash
 
pledged
 
(if any),
 
including
 
accrued
 
interest
 
on such securities)
 
with all
 
counterparties
 
of approximately
 
$
117.4
million.
 
The Company
 
did not
 
have an amount
 
at risk with
 
any individual
 
counterparty
 
that was
 
greater than
 
10% of the
 
Company’s equity
at September
 
30, 2022
 
and December
 
31, 2021.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12
NOTE 4. DERIVATIVE AND OTHER HEDGING INSTRUMENTS
The table
 
below summarizes
 
fair value
 
information
 
about the
 
Company’s derivative
 
and other
 
hedging instruments
 
assets and
liabilities
 
as of September
 
30, 2022
 
and December
 
31, 2021.
(in thousands)
Derivative and Other Hedging Instruments
Balance Sheet Location
September 30, 2022
December 31, 2021
Assets
Interest rate swaps
Derivative assets, at fair value
$
169,630
$
29,293
Payer swaptions (long positions)
Derivative assets, at fair value
91,195
21,493
Interest rate caps
Derivative assets, at fair value
1,188
-
TBA securities
Derivative assets, at fair value
305
-
Total derivative
 
assets, at fair value
$
262,318
$
50,786
Liabilities
Interest rate swaps
Derivative liabilities, at fair value
$
-
$
2,862
Payer swaptions (short positions)
Derivative liabilities, at fair value
52,315
4,423
TBA securities
Derivative liabilities, at fair value
698
304
Total derivative
 
liabilities, at fair value
$
53,013
$
7,589
Margin Balances Posted to (from) Counterparties
Futures contracts
Restricted cash
$
16,056
$
8,035
TBA securities
Restricted cash
1,336
-
TBA securities
Other liabilities
(11,422)
(856)
Interest rate swaption contracts
Other liabilities
(27,149)
(6,350)
Total margin
 
balances on derivative contracts
$
(21,179)
$
829
Eurodollar, Fed
 
Funds and
 
T-Note futures
 
are cash
 
settled futures
 
contracts
 
on an interest
 
rate, with
 
gains and
 
losses credited
 
or
charged to
 
the Company’s
 
cash accounts
 
on a daily
 
basis. A
 
minimum balance,
 
or “margin”,
 
is required
 
to be maintained
 
in the account
 
on
a daily basis.
The tables
 
below present
 
information
 
related to
 
the Company’s
 
T-Note futures
 
positions
 
at September
 
30, 2022
 
and
December
 
31, 2021.
 
($ in thousands)
September 30, 2022
Average
Weighted
Weighted
Contract
Average
Average
Notional
Entry
Effective
Open
Expiration Year
Amount
Rate
Rate
Equity
(1)
Treasury Note Futures Contracts (Short
 
Positions)
(2)
December 2022 5-year T-Note futures
(Dec 2022 - Dec 2027 Hedge Period)
$
750,500
3.54%
4.32%
$
29,141
December 2022 10-year Ultra futures
(Dec 2022 - Dec 2032 Hedge Period)
$
174,500
3.03%
3.77%
$
13,141
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13
($ in thousands)
December 31, 2021
Average
Weighted
Weighted
Contract
Average
Average
Notional
Entry
Effective
Open
Expiration Year
Amount
Rate
Rate
Equity
(1)
Treasury Note Futures Contracts (Short
 
Position)
(2)
March 2022 5-year T-Note futures
(Mar 2022 - Mar 2027 Hedge Period)
$
369,000
1.56%
1.62%
$
1,013
March 2022 10-year Ultra futures
(Mar 2022 - Mar 2032 Hedge Period)
$
220,000
1.22%
1.09%
$
(3,861)
(1)
Open equity represents the cumulative gains (losses) recorded on open
 
futures positions from inception.
(2)
5-Year T-Note
 
futures contracts were valued at a price of $
107.51
 
at September 30, 2022 and $
120.98
 
at December 31, 2021.
 
The contract
values of the short positions were $
806.8
 
million and $
446.4
 
million at September 30, 2022 and December 31, 2021, respectively.
 
10-Year Ultra
futures contracts were valued at a price of $
118.48
 
at September 30, 2022 and $
146.44
 
at December 31, 2021. The contract value of the short
position was $
206.8
 
million and $
322.2
 
million at September 30, 2022 and December 31, 2021, respectively
Under its
 
interest
 
rate swap
 
agreements,
 
the Company
 
typically
 
pays
 
a fixed rate
 
and receive
 
a floating
 
rate based
 
on an index
("payer swaps").
 
The floating
 
rate the
 
Company receives
 
under its
 
swap agreements
 
has the effect
 
of offsetting
 
the repricing
characteristics
 
of our repurchase
 
agreements
 
and cash flows
 
on such liabilities.
 
The Company
 
is typically
 
required
 
to post collateral
 
on its
interest rate
 
swap agreements.
 
The table
 
below presents
 
information
 
related to
 
the Company’s
 
interest
 
rate swap
 
positions
 
at September
30, 2022
 
and December
 
31, 2021.
($ in thousands)
Average
Net
Fixed
Average
Estimated
Average
Notional
Pay
Receive
Fair
Maturity
Amount
Rate
Rate
Value
(Years)
September 30, 2022
Expiration > 3 to ≤ 5 years
$
500,000
0.84%
3.46%
$
60,776
4.0
Expiration > 5 years
900,000
1.70%
2.56%
108,854
6.8
$
1,400,000
1.39%
2.88%
$
169,630
5.8
December 31, 2021
Expiration > 3 to ≤ 5 years
$
955,000
0.64%
0.16%
$
21,788
4.0
Expiration > 5 years
400,000
1.16%
0.21%
4,643
7.3
$
1,355,000
0.79%
0.18%
$
26,431
5.0
The table
 
below presents
 
information
 
related to
 
the Company’s
 
interest
 
rate cap positions
 
at September
 
30, 2022.
($ in thousands)
Net
Strike
Estimated
Notional
Swap
Curve
Fair
Expiration
Amount
Cost
Rate
Spread
Value
February 8, 2024
$
200,000
$
1,450
0.09%
2Y10Y
$
1,188
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14
The table
 
below presents
 
information
 
related to
 
the Company’s
 
interest
 
rate swaption
 
positions
 
at September
 
30, 2022
 
and
 
December
31, 2021.
($ in thousands)
Option
Underlying Swap
Weighted
Average
Weighted
Average
Average
Adjustable
Average
Fair
Months to
Notional
Fixed
Rate
Term
Expiration
Cost
Value
Expiration
Amount
Rate
(LIBOR)
(Years)
September 30, 2022
Payer Swaptions - long
≤ 1 year
$
35,230
$
83,470
10.6
$
1,303,600
2.95%
3 Month
10.0
>10 years
7,267
7,725
238.9
80,000
2.07%
3 Month
10.0
$
42,497
$
91,195
23.8
$
1,383,600
2.90%
3 Month
10.0
Payer Swaptions - short
≤ 1 year
$
(17,500)
$
52,315
4.7
$
(958,300)
2.95%
3 Month
10.0
December 31, 2021
Payer Swaptions - long
≤ 1 year
$
4,000
$
1,575
3.2
$
400,000
1.66%
3 Month
5.0
>1 year ≤ 2 years
32,690
19,918
18.4
1,258,500
2.46%
3 Month
14.1
$
36,690
$
21,493
14.7
$
1,658,500
2.27%
3 Month
11.9
Payer Swaptions - short
≤ 1 year
$
(16,185)
$
(4,423)
5.3
$
(1,331,500)
2.29%
3 Month
11.4
The
 
following
 
table
 
summarizes
 
the
 
Company’s
 
contracts
 
to
 
purchase
 
and
 
sell
 
TBA
 
securities
 
as
 
of
 
September
 
30,
 
2022
 
and
December 31, 2021.
($ in thousands)
Notional
Net
Amount
Cost
Market
Carrying
Long (Short)
(1)
Basis
(2)
Value
(3)
Value
(4)
September 30, 2022
30-Year TBA securities:
2.0%
$
(175,000)
$
(141,329)
$
(141,723)
$
(394)
3.0%
(300,000)
(261,047)
(261,047)
-
Total
$
(475,000)
$
(402,376)
$
(402,770)
$
(394)
December 31, 2021
30-Year TBA securities:
3.0%
$
(575,000)
$
(595,630)
$
(595,934)
$
(304)
Total
$
(575,000)
$
(595,630)
$
(595,934)
$
(304)
(1)
Notional amount represents the par value (or principal balance) of the underlying
 
Agency RMBS.
(2)
Cost basis represents the forward price to be paid (received) for the underlying
 
Agency RMBS.
(3)
Market value represents the current market value of the TBA securities
 
(or of the underlying Agency RMBS) as of period-end.
(4)
Net carrying value represents the difference between the market
 
value and the cost basis of the TBA securities as of period-end and
 
is reported
in derivative assets (liabilities) at fair value in the balance sheets.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15
Gain (Loss) From Derivative and Other Hedging Instruments, Net
The table below presents the effect of the Company’s derivative and other hedging instruments on the statements of operations for
the nine and three months ended September 30, 2022 and 2021.
(in thousands)
Nine Months Ended September 30,
Three Months Ended September 30,
2022
2021
2022
2021
T-Note futures contracts (short position)
$
207,681
$
866
$
84,713
$
581
Eurodollar futures contracts (short positions)
-
(14)
-
(7)
Interest rate swaps
172,069
12,446
65,966
3,000
Payer swaptions (short positions)
(80,183)
3,507
(35,239)
2,295
Payer swaptions (long positions)
150,445
5,477
59,131
1,767
Interest rate caps
988
-
(499)
-
Interest rate floors
-
1,345
-
45
TBA securities (short positions)
14,194
864
10,642
(2,306)
TBA securities (long positions)
1,200
(8,559)
106
-
Total
$
466,394
$
15,932
$
184,820
$
5,375
Credit Risk-Related Contingent Features
The
 
use
 
of
 
derivatives
 
and
 
other
 
hedging
 
instruments
 
creates
 
exposure
 
to
 
credit
 
risk
 
relating
 
to
 
potential
 
losses
 
that
 
could
 
be
recognized in the event
 
that the counterparties to these
 
instruments fail to perform their
 
obligations under the contracts. The
 
Company
attempts to minimize
 
this risk by
 
limiting its counterparties
 
for instruments which
 
are not centrally
 
cleared on a
 
registered exchange to
major financial institutions
 
with acceptable credit
 
ratings and
 
monitoring positions with
 
individual counterparties. In
 
addition, the Company
may be
 
required to
 
pledge assets
 
as collateral
 
for its
 
derivatives, whose
 
amounts vary over
 
time based
 
on the
 
market value, notional
amount and remaining
 
term of
 
the derivative contract.
 
In the event
 
of a default
 
by a counterparty, the
 
Company may
 
not receive payments
provided
 
for
 
under
 
the
 
terms
 
of
 
its
 
derivative
 
agreements,
 
and
 
may
 
have
 
difficulty
 
obtaining
 
its
 
assets
 
pledged
 
as
 
collateral
 
for
 
its
derivatives. The cash and cash equivalents pledged as collateral for the Company derivative instruments
 
are included in restricted cash
on its balance sheets.
It is the Company's policy not
 
to offset assets and liabilities associated
 
with open derivative contracts. However, Chicago
 
Mercantile
Exchange
 
(“CME”)
 
and
 
Intercontinental
 
Exchange
 
(“ICE”)
 
rules
 
characterize
 
variation
 
margin
 
transfers
 
as
 
settlement
 
payments,
 
as
opposed to adjustments to collateral. As
 
a result, derivative assets and liabilities
 
associated with centrally cleared derivatives for
 
which
the CME or ICE serves as the central clearing party are presented as if these derivatives
 
had been settled as of the reporting date.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16
NOTE 5. PLEDGED ASSETS
Assets Pledged
 
to Counterparties
The table
 
below summarizes
 
the Company’s
 
assets pledged
 
as collateral
 
under repurchase
 
agreements
 
and derivative
 
agreements
by type, including
 
securities
 
pledged
 
related to
 
securities
 
sold but
 
not yet settled,
 
as of September
 
30, 2022
 
and December
 
31, 2021.
(in thousands)
September 30, 2022
December 31, 2021
Repurchase
Derivative
Repurchase
Derivative
Assets Pledged to Counterparties
Agreements
Agreements
Total
Agreements
Agreements
Total
PT RMBS - fair value
$
3,145,035
$
-
$
3,145,035
$
6,294,102
$
-
$
6,294,102
Structured RMBS - fair value
50,811
-
50,811
212,270
-
212,270
U.S. Treasury Notes
-
36,118
36,118
-
29,740
29,740
Accrued interest on pledged securities
10,507
4
10,511
18,804
13
18,817
Restricted cash
49,377
17,392
66,769
57,264
8,035
65,299
Total
$
3,255,730
$
53,514
$
3,309,244
$
6,582,440
$
37,788
$
6,620,228
Assets Pledged
 
from Counterparties
The table
 
below summarizes
 
assets pledged
 
to the Company
 
from counterparties
 
under repurchase
 
agreements
 
and derivative
agreements
 
as of September
 
30, 2022
 
and December
 
31, 2021.
(in thousands)
September 30, 2022
December 31, 2021
Repurchase
Derivative
Repurchase
Derivative
Assets Pledged to Orchid
Agreements
Agreements
Total
Agreements
Agreements
Total
Cash
$
-
$
38,571
$
38,571
$
4,339
$
7,206
$
11,545
Total
$
-
$
38,571
$
38,571
$
$
4,339
$
7,206
$
11,545
Cash received
 
as margin
 
is recognized
 
as cash and
 
cash equivalents
 
with a corresponding
 
amount recognized
 
as an increase
 
in
repurchase
 
agreements
 
or other
 
liabilities
 
in the balance
 
sheets.
NOTE 6. OFFSETTING ASSETS AND LIABILITIES
The Company’s
 
derivative
 
agreements
 
and repurchase
 
agreements
 
and reverse
 
repurchase
 
agreements
 
are subject
 
to underlying
agreements
 
with master
 
netting or
 
similar arrangements,
 
which provide
 
for the right
 
of offset in
 
the event
 
of default
 
or in the
 
event of
bankruptcy
 
of either
 
party to
 
the transactions.
 
The Company
 
reports its
 
assets and
 
liabilities
 
subject to
 
these arrangements
 
on a gross
basis.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17
The following
 
table presents
 
information
 
regarding
 
those assets
 
and liabilities
 
subject to
 
such arrangements
 
as if the
 
Company had
presented
 
them on a
 
net basis
 
as of September
 
30, 2022
 
and December
 
31, 2021.
(in thousands)
Offsetting of Assets
Gross Amount Not
Net Amount
Offset in the Balance Sheet
of Assets
Financial
Gross Amount
Gross Amount
Presented
Instruments
Cash
of Recognized
Offset in the
in the
Received as
Received as
Net
Assets
Balance Sheet
Balance Sheet
Collateral
Collateral
Amount
September 30, 2022
Interest rate swaps
$
169,630
$
-
$
169,630
$
-
$
-
$
169,630
Interest rate swaptions
91,195
-
91,195
-
(27,149)
64,046
Interest rate caps
1,188
-
1,188
-
-
1,188
TBA securities
305
-
305
-
(305)
-
$
262,318
$
-
$
262,318
$
-
$
(27,454)
$
234,864
December 31, 2021
Interest rate swaps
$
29,293
$
-
$
29,293
$
-
$
-
$
29,293
Interest rate swaptions
21,493
-
21,493
-
(6,350)
15,143
$
50,786
$
-
$
50,786
$
-
$
(6,350)
$
44,436
(in thousands)
Offsetting of Liabilities
Gross Amount Not
Net Amount
Offset in the Balance Sheet
of Liabilities
Financial
Gross Amount
Gross Amount
Presented
Instruments
of Recognized
Offset in the
in the
Posted as
Cash Posted
Net
Liabilities
Balance Sheet
Balance Sheet
Collateral
as Collateral
Amount
September 30, 2022
Repurchase Agreements
$
3,133,861
$
-
$
3,133,861
$
(3,084,484)
$
(49,377)
$
-
Interest rate swaptions
52,315
-
52,315
-
-
52,315
TBA securities
698
-
698
-
(698)
-
$
3,186,874
$
-
$
3,186,874
$
(3,084,484)
$
(50,075)
$
52,315
December 31, 2021
Repurchase Agreements
$
6,244,106
$
-
$
6,244,106
$
(6,186,842)
$
(57,264)
$
-
Interest rate swaps
2,862
-
2,862
(2,862)
-
-
Interest rate swaptions
4,423
-
4,423
-
-
4,423
TBA securities
304
-
304
-
-
304
$
6,251,695
$
-
$
6,251,695
$
(6,189,704)
$
(57,264)
$
4,727
The amounts
 
disclosed
 
for collateral
 
received by
 
or posted
 
to the same
 
counterparty
 
up to and
 
not exceeding
 
the net amount
 
of the
asset or
 
liability
 
presented
 
in the balance
 
sheets.
 
The fair
 
value of
 
the actual
 
collateral
 
received
 
by or posted
 
to the same
 
counterparty
typically
 
exceeds the
 
amounts
 
presented.
 
See Note
 
5 for a discussion
 
of collateral
 
posted or
 
received
 
against or
 
for repurchase
 
obligations
and derivative
 
and other
 
hedging
 
instruments.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
18
NOTE 7.
 
CAPITAL STOCK
Reverse
 
Stock Split
On August
 
30, 2022,
 
the Company
 
effected a
 
1-for-5 reverse
 
stock split
 
of its common
 
stock and
 
proportionately
 
decreased
 
the
number of
 
authorized
 
shares of
 
common stock.
 
All share,
 
per share,
 
deferred
 
stock unit
 
(“DSU”)
 
and performance
 
unit information
 
has
been retroactively
 
adjusted to
 
reflect
 
the reverse
 
split.
 
The shares
 
of common
 
stock retain
 
a par value
 
of $0.01
 
per share.
 
Common Stock
 
Issuances
The Company
 
did not complete
 
any public
 
offerings of
 
its common
 
stock during
 
the nine
 
months ended
 
September
 
30, 2022.
 
During
the year
 
ended December
 
31, 2021,
 
the Company
 
completed
 
the following
 
public offerings
 
of shares
 
of its common
 
stock.
 
($ in thousands, except per share amounts)
Weighted
Average
Price
Received
Net
Type of Offering
Period
Per Share
(1)
Shares
Proceeds
(2)
At the Market Offering Program
(3)
First Quarter
$
25.50
61,610
$
1,572
Follow-on Offerings
First Quarter
26.55
3,588,000
95,336
At the Market Offering Program
(3)
Second Quarter
27.00
4,617,418
124,746
At the Market Offering Program
(3)
Third Quarter
24.70
7,163,668
177,007
At the Market Offering Program
(3)
Fourth Quarter
24.35
4,734,940
115,398
20,165,636
$
514,059
(1)
Weighted average price received per share is after deducting the underwriters’
 
discount, if applicable, and other offering costs.
(2)
Net proceeds are net of the underwriters’ discount, if applicable, and other
 
offering costs.
(3)
The Company has entered into ten equity distribution agreements, nine of which have
 
either been terminated because all shares were sold or
were replaced with a subsequent agreement.
Stock Repurchase Program
On July 29, 2015, the Company’s Board of Directors authorized the repurchase of up to
400,000
 
shares of the Company’s
common stock. On February 8, 2018, the Board of Directors approved an increase
 
in the stock repurchase program for up to an
additional
904,564
 
shares of the Company's common stock. Coupled with the
156,751
 
shares remaining from the original
400,000
share authorization, the increased authorization brought the total authorization
 
to
1,061,316
 
shares, representing 10% of the
Company’s then outstanding share count.
 
On December 9, 2021, the Board of Directors approved an increase in the
 
number of shares of the Company’s common stock
available in the stock repurchase program for up to an additional
3,372,399
 
shares, bringing the remaining authorization under the
stock repurchase program to
3,539,861
 
shares, representing approximately 10% of the Company’s then outstanding shares of
common stock.
On October 12, 2022, the Board of Directors approved an increase
 
in the number of shares of the Company’s common stock
available in the stock repurchase program for up to an additional
4,300,000
 
shares, bringing the remaining authorization under the
stock repurchase program to
6,183,601
 
shares, representing approximately 18% of the Company’s then outstanding shares
 
of
common stock.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19
As part of the stock repurchase program, shares may be purchased in open market
 
transactions, block purchases, through
privately negotiated transactions, or pursuant to any trading plan that may be adopted
 
in accordance with Rule 10b5-1 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”).
 
Open market repurchases will be made in accordance with Exchange Act
Rule 10b-18, which sets certain restrictions on the method, timing, price
 
and volume of open market stock repurchases. The timing,
manner, price and amount of any repurchases will be determined by the Company in its discretion and will be subject
 
to economic and
market conditions, stock price, applicable legal requirements and other factors.
 
The authorization does not obligate the Company to
acquire any particular amount of common stock and the program may
 
be suspended or discontinued at the Company’s discretion
without prior notice. The stock repurchase program has no termination date.
From the inception of the stock repurchase program through September 30, 2022,
 
the Company repurchased a total of
1,487,362
shares at an aggregate cost of approximately $
44.8
 
million, including commissions and fees, for a weighted average price
 
of $30.12
per share. During the nine months ended September 30, 2022, the Company repurchased
 
a total of
350,260
 
shares at an aggregate
cost of approximately $
4.4
 
million, including commissions and fees, for a weighted average
 
price of $
12.68
 
per share. No shares were
repurchased during the year ended December 31, 2021. Subsequent to September
 
30, 2022, and through October 27, 2022, the
Company repurchased a total of
1,644,044
 
shares at an aggregate cost of approximately $
14.2
 
million, including commissions and
fees, for a weighted average price of $
8.64
 
per share. The remaining authorization under the stock repurchase
 
program as of October
27, 2022 was
5,845,557
 
shares.
 
Cash Dividends
The table below presents the cash dividends declared on the Company’s common
 
stock.
(in thousands, except per share amounts)
Year
Per Share
Amount
Total
2013
$
6.975
$
4,662
2014
10.800
22,643
2015
9.600
38,748
2016
8.400
41,388
2017
8.400
70,717
2018
5.350
55,814
2019
4.800
54,421
2020
3.950
53,570
2021
3.900
97,601
2022 - YTD
(1)
2.155
76,024
Totals
$
64.330
$
515,588
(1)
On
October 12, 2022
, the Company declared a dividend of $
0.16
 
per share to be paid on
November 28, 2022
.
 
The effect of this dividend is
included in the table above but is not reflected in the Company’s financial
 
statements as of September 30, 2022.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20
NOTE 8.
 
STOCK INCENTIVE PLAN
In 2021,
 
the Company’s
 
Board of
 
Directors
 
adopted,
 
and the stockholders
 
approved,
 
the Orchid
 
Island Capital,
 
Inc. 2021
 
Equity
Incentive
 
Plan (the
 
“2021 Incentive
 
Plan”) to
 
replace the
 
Orchid Island
 
Capital,
 
Inc. 2012
 
Equity Incentive
 
Plan (the
 
“2012 Incentive
 
Plan”
and together
 
with the
 
2021 Incentive
 
Plan, the
 
“Incentive
 
Plans”).
 
The 2021
 
Incentive
 
Plan provides
 
for the award
 
of stock options,
 
stock
appreciation
 
rights, stock
 
award, performance
 
units, other
 
equity-based
 
awards (and
 
dividend equivalents
 
with respect
 
to awards
 
of
performance
 
units and
 
other equity-based
 
awards) and
 
incentive
 
awards.
 
The 2021
 
Incentive
 
Plan is administered
 
by the Compensation
Committee
 
of the Company’s
 
Board of
 
Directors
 
except that
 
the Company’s
 
full Board
 
of Directors
 
will administer
 
awards made
 
to directors
who are
 
not employees
 
of the Company
 
or its affiliates.
 
The 2021
 
Incentive
 
Plan provides
 
for awards
 
of up to
 
an aggregate
 
of
10
% of the
issued and
 
outstanding
 
shares of
 
the Company’s
 
common stock
 
(on a fully
 
diluted basis)
 
at the time
 
of the awards,
 
subject to
 
a maximum
aggregate
1,473,324
 
shares of
 
the Company’s
 
common stock
 
that may
 
be issued
 
under the
 
2021 Incentive
 
Plan. The
 
2021 Incentive
 
Plan
replaces the
 
2012 Incentive
 
Plan, and
 
no further
 
grants will
 
be made under
 
the 2012
 
Incentive
 
Plan.
 
However, any
 
outstanding
 
awards
under the
 
2012 Incentive
 
Plan will
 
continue in
 
accordance
 
with the
 
terms of
 
the 2012
 
Incentive
 
Plan and
 
any award
 
agreement
 
executed in
connection
 
with such
 
outstanding
 
awards.
 
Performance
 
Units
The Company
 
has issued,
 
and may
 
in the future
 
issue additional,
 
performance
 
units under
 
the Incentive
 
Plans to
 
certain executive
officers and
 
employees
 
of its Manager.
 
“Performance
 
Units” vest
 
after the
 
end of a
 
defined performance
 
period, based
 
on satisfaction
 
of
the performance
 
conditions
 
set forth
 
in the performance
 
unit agreement.
 
When earned,
 
each Performance
 
Unit will
 
be settled
 
by the
issuance of
 
one share
 
of the Company’s
 
common stock,
 
at which
 
time the
 
Performance
 
Unit will
 
be cancelled.
 
The Performance
 
Units
contain dividend
 
equivalent
 
rights, which
 
entitle the
 
Participants
 
to receive
 
distributions
 
declared
 
by the Company
 
on common
 
stock, but
 
do
not include
 
the right
 
to vote the
 
underlying
 
shares of
 
common stock.
 
Performance
 
Units are
 
subject to
 
forfeiture
 
should the
 
participant
 
no
longer serve
 
as an executive
 
officer or
 
employee of
 
the Company
 
or the Manager.
 
Compensation
 
expense for
 
the Performance
 
Units,
included in
 
incentive
 
compensation
 
on the statements
 
of operations,
 
is recognized
 
over the
 
remaining
 
vesting period
 
once it becomes
probable
 
that the
 
performance
 
conditions
 
will be achieved.
The following
 
table presents
 
information
 
related to
 
Performance
 
Units outstanding
 
during the
 
nine months
 
ended September
 
30, 2022
and 2021.
($ in thousands, except per share data)
Nine Months Ended September 30,
2022
2021
Weighted
Weighted
Average
Average
Grant Date
Grant Date
 
Shares
Fair Value
Shares
Fair Value
Unvested, beginning of period
26,645
$
29.40
911
$
37.25
Granted
35,114
16.55
27,579
29.40
Forfeited
(8,464)
21.40
-
-
Vested and issued
(7,594)
29.40
(911)
37.25
Unvested, end of period
45,701
$
21.01
27,579
$
29.40
Compensation expense during period
$
331
$
222
Unrecognized compensation expense, end of period
$
535
$
592
Intrinsic value, end of period
$
375
$
674
Weighted-average remaining vesting term (in years)
1.4
1.6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21
The number
 
of shares
 
of common
 
stock issuable
 
upon the
 
vesting of
 
the remaining
 
outstanding
 
Performance
 
Units was
 
reduced as a
result of
 
the book
 
value impairment
 
event that
 
occurred
 
pursuant
 
to the terms
 
of the long
 
term equity
 
incentive
 
compensation
 
plans (the
“Plans”)
 
established
 
under the
 
Company’s 2012
 
Equity Incentive
 
Plan and
 
2021 Equity
 
Incentive
 
Plan. The
 
book value
 
impairment
 
event
occurred
 
when the
 
Company's
 
book value
 
per share
 
declined
 
by more than
 
15% during
 
the quarter
 
ended March
 
31, 2022
 
and the
Company’s book
 
value per
 
share decline
 
from January
 
1, 2022 to
 
June 30,
 
2022 was
 
more than
 
10%. The
 
Plans provide
 
that if such
 
a
book value
 
impairment
 
event occurs,
 
then the
 
number of
 
outstanding
 
Performance
 
Units that
 
are outstanding
 
as of the
 
last day of
 
such two
quarter period
 
shall be reduced
 
by 15%.
Stock Awards
The Company
 
has issued,
 
and may
 
in the future
 
issue additional,
 
immediately
 
vested common
 
stock under
 
the Incentive
 
Plans to
certain executive
 
officers and
 
employees
 
of its Manager.
The following
 
table presents
 
information
 
related to
 
fully vested
 
common stock
issued during
 
the nine months
 
ended September
 
30, 2022
 
and 2021.
 
All of the
 
fully vested
 
shares of
 
common stock
 
issued during
 
the nine
months ended
 
September
 
30, 2022
 
and 2021,
 
and the related
 
compensation
 
expense, were
 
granted with
 
respect to
 
service performed
during the
 
fiscal years
 
ended December
 
31, 2021
 
and 2020,
 
respectively.
($ in thousands, except per share data)
Nine Months Ended September 30,
2022
2021
Fully vested shares granted
35,114
27,579
Weighted average grant date price per share
$
16.55
$
29.40
Compensation expense related to fully vested shares of common stock awards
$
581
$
811
Deferred
 
Stock Units
Non-employee
 
directors
 
receive a
 
portion of
 
their compensation
 
in the form
 
of DSU awards
 
pursuant
 
to the Incentive
 
Plans.
 
Each
DSU represents
 
a right to
 
receive one
 
share of
 
the Company’s
 
common stock.
 
Beginning
 
in 2022,
 
each non-employee
 
director
 
can elect
 
to
receive all
 
of his or
 
her compensation
 
in the form
 
of DSUs.
 
The DSUs
 
are immediately
 
vested and
 
are settled
 
at a future
 
date based
 
on the
election of
 
the individual
 
participant.
 
Compensation
 
expense for
 
the DSUs
 
is included
 
in directors’
 
fees and
 
liability insurance
 
in the
statements
 
of operations.
 
The DSUs
 
contain dividend
 
equivalent
 
rights, which
 
entitle the
 
participant
 
to receive
 
distributions
 
declared
 
by the
Company on
 
common stock.
 
These dividend
 
equivalent
 
rights
 
are settled
 
in cash or
 
additional
 
DSUs at
 
the participant’s
 
election.
 
The
DSUs do
 
not include
 
the right
 
to vote the
 
underlying
 
shares of
 
common stock.
 
The following
 
table presents
 
information
 
related to
 
the DSUs
 
outstanding
 
during the
 
nine months
 
ended September
 
30, 2022
 
and
2021.
($ in thousands, except per share data)
Nine Months Ended September 30,
2022
2021
Weighted
Weighted
Average
Average
Grant Date
Grant Date
 
Shares
Fair Value
Shares
Fair Value
Outstanding, beginning of period
28,595
$
26.92
18,189
$
27.20
Granted and vested
14,227
16.52
7,337
27.30
Outstanding, end of period
42,822
$
23.46
25,526
$
27.20
Compensation expense during period
$
239
$
180
Intrinsic value, end of period
$
351
$
624
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22
NOTE 9.
 
COMMITMENTS AND CONTINGENCIES
From time to time, the Company may become involved in various claims and
 
legal actions arising in the ordinary course of
business. Management is not aware of any reported or unreported contingencies
 
at September 30, 2022.
NOTE 10. INCOME TAXES
The Company will generally not be subject to U.S. federal income tax on
 
its REIT taxable income to the extent that it distributes its
REIT taxable income to its stockholders and satisfies the ongoing REIT requirements,
 
including meeting certain asset, income and
stock ownership tests.
 
A REIT must generally distribute at least 90% of its REIT taxable income,
 
determined without regard to the
deductions for dividends paid and excluding net capital gain, to its stockholders,
 
annually to maintain REIT status.
 
An amount equal to
the sum of which 85% of its REIT ordinary income and 95% of its REIT
 
capital gain net income, plus certain undistributed income from
prior taxable years, must be distributed within the taxable year, in order to avoid the imposition of an excise tax.
 
The remaining
balance may be distributed up to the end of the following taxable year, provided the REIT elects to treat such amount
 
as a prior year
distribution and meets certain other requirements.
 
NOTE 11.
 
EARNINGS PER SHARE (EPS)
The Company
 
had dividend
 
eligible
 
Performance
 
Units and
 
Deferred
 
Stock Units
 
that were
 
outstanding
 
during the
 
nine and
 
three
months ended
 
September
 
30, 2022
 
and 2021.
 
The basic
 
and diluted
 
per share
 
computations
 
include these
 
unvested Performance
 
Units
and Deferred
 
Stock Units
 
if there is
 
income available
 
to common
 
stock, as
 
they have
 
dividend
 
participation
 
rights. The
 
unvested
Performance
 
Units and
 
Deferred
 
Stock Units
 
have no contractual
 
obligation
 
to share
 
in losses.
 
Because there
 
is no such
 
obligation,
 
the
unvested Performance
 
Units and
 
Deferred
 
Stock Units
 
are not included
 
in the basic
 
and diluted
 
EPS computations
 
when no income
 
is
available
 
to common
 
stock even
 
though they
 
are considered
 
participating
 
securities.
The table
 
below reconciles
 
the numerator
 
and denominator
 
of EPS for
 
the nine
 
and three
 
months ended
 
September
 
30, 2022
 
and
2021.
(in thousands, except per share information)
Nine Months Ended September 30,
Three Months Ended September 30,
2022
2021
2022
2021
Basic and diluted EPS per common share:
Numerator for basic and diluted EPS per share of common stock:
Net (loss) income - Basic and diluted
$
(293,380)
$
(20,196)
$
(84,514)
$
26,038
Weighted average shares of common stock:
Shares of common stock outstanding at the balance sheet date
35,066
30,664
35,066
30,664
Unvested dividend eligible share based compensation
outstanding at the balance sheet date
-
-
-
53
Effect of weighting
 
271
(9,603)
140
(5,000)
Weighted average shares-basic and diluted
35,337
21,061
35,206
25,717
Net (loss) income per common share:
Basic and diluted
$
(8.31)
$
(0.95)
$
(2.40)
$
1.00
Anti-dilutive incentive shares not included in calculation
89
53
89
-
23
NOTE 12.
 
FAIR VALUE
The framework
 
for using
 
fair value
 
to measure
 
assets and
 
liabilities
 
defines fair
 
value as the
 
price that
 
would be
 
received to
 
sell an
asset or
 
paid to transfer
 
a liability
 
(an exit
 
price). A
 
fair value
 
measure should
 
reflect the
 
assumptions
 
that market
 
participants
 
would use
 
in
pricing the
 
asset or
 
liability, including
 
the assumptions
 
about the
 
risk inherent
 
in a particular
 
valuation
 
technique,
 
the effect of
 
a restriction
on the sale
 
or use of
 
an asset and
 
the risk of
 
non-performance.
 
Required
 
disclosures
 
include stratification
 
of balance
 
sheet amounts
measured
 
at fair value
 
based on
 
inputs the
 
Company uses
 
to derive
 
fair value
 
measurements.
 
These stratifications
 
are:
 
●
Level 1 valuations,
 
where the
 
valuation
 
is based on
 
quoted market
 
prices for
 
identical
 
assets or
 
liabilities
 
traded in
 
active markets
(which include
 
exchanges
 
and over-the-counter
 
markets with
 
sufficient
 
volume),
 
●
Level 2 valuations,
 
where the
 
valuation
 
is based on
 
quoted market
 
prices for
 
similar instruments
 
traded in
 
active markets,
 
quoted
prices for
 
identical
 
or similar
 
instruments
 
in markets
 
that are
 
not active
 
and model-based
 
valuation
 
techniques
 
for which
 
all
significant
 
assumptions
 
are observable
 
in the market,
 
and
●
Level 3 valuations,
 
where the
 
valuation
 
is generated
 
from model-based
 
techniques
 
that use
 
significant
 
assumptions
 
not
observable
 
in the market,
 
but observable
 
based on
 
Company-specific
 
data. These
 
unobservable
 
assumptions
 
reflect the
Company’s own
 
estimates
 
for assumptions
 
that market
 
participants
 
would use
 
in pricing
 
the asset
 
or liability. Valuation
techniques
 
typically
 
include option
 
pricing models,
 
discounted
 
cash flow
 
models and
 
similar techniques,
 
but may also
 
include the
use of market
 
prices of
 
assets or
 
liabilities
 
that are
 
not directly
 
comparable
 
to the subject
 
asset or
 
liability.
The Company's
 
RMBS and
 
TBA securities
 
are Level
 
2 valuations,
 
and such valuations
 
currently
 
are determined
 
by the Company
based on
 
independent
 
pricing sources
 
and/or third
 
party broker
 
quotes. Because
 
the price
 
estimates
 
may vary, the Company
 
must make
certain judgments
 
and assumptions
 
about the
 
appropriate
 
price to
 
use to calculate
 
the fair
 
values. The
 
Company and
 
the independent
pricing sources
 
use various
 
valuation
 
techniques
 
to determine
 
the price
 
of the Company’s
 
securities.
 
These techniques
 
include observing
the most
 
recent market
 
for like
 
or identical
 
assets (including
 
security
 
coupon, maturity,
 
yield, and
 
prepayment
 
speeds), spread
 
pricing
techniques
 
to determine
 
market credit
 
spreads (option
 
adjusted spread,
 
zero volatility
 
spread,
 
spread to
 
the U.S.
 
Treasury curve
 
or spread
to a benchmark
 
such as a
 
TBA), and
 
model driven
 
approaches
 
(the discounted
 
cash flow
 
method,
 
Black Scholes
 
and SABR
 
models which
rely upon
 
observable
 
market rates
 
such as the
 
term structure
 
of interest
 
rates and
 
volatility).
 
The appropriate
 
spread pricing
 
method used
is based on
 
market convention.
 
The pricing
 
source determines
 
the spread
 
of recently
 
observed
 
trade activity
 
or observable
 
markets for
assets similar
 
to those
 
being priced.
 
The spread
 
is then adjusted
 
based on
 
variances
 
in certain
 
characteristics
 
between the
 
market
observation
 
and the asset
 
being priced.
 
Those characteristics
 
include: type
 
of asset,
 
the expected
 
life of the
 
asset, the
 
stability
 
and
predictability
 
of the expected
 
future cash
 
flows of
 
the asset,
 
whether
 
the coupon
 
of the asset
 
is fixed
 
or adjustable,
 
the guarantor
 
of the
security if
 
applicable,
 
the coupon,
 
the maturity, the
 
issuer, size of
 
the underlying
 
loans, year
 
in which
 
the underlying
 
loans
 
were originated,
loan to value
 
ratio, state
 
in which
 
the underlying
 
loans reside,
 
credit score
 
of the underlying
 
borrowers
 
and other
 
variables if
 
appropriate.
The fair
 
value of the
 
security is
 
determined
 
by using the
 
adjusted
 
spread.
 
The Company’s
 
U.S. Treasury
 
Notes are
 
based on
 
quoted prices
 
for identical
 
instruments
 
in active
 
markets and
 
are classified
 
as
Level 1 assets.
The Company’s
 
futures contracts
 
are Level
 
1 valuations,
 
as they are
 
exchange-traded
 
instruments
 
and quoted
 
market prices
 
are
readily available.
 
Futures contracts
 
are settled
 
daily. The Company’s
 
interest
 
rate swaps
 
and interest
 
rate swaptions
 
are Level
 
2
valuations.
 
The fair
 
value of interest
 
rate swaps
 
is determined
 
using a discounted
 
cash flow
 
approach
 
using forward
 
market interest
 
rates
and discount
 
rates, which
 
are observable
 
inputs. The
 
fair value
 
of interest
 
rate swaptions
 
is determined
 
using an option
 
pricing model.
 
RMBS (based
 
on the fair
 
value option),
 
derivatives
 
and TBA securities
 
were recorded
 
at fair value
 
on a recurring
 
basis during
 
the nine
and three
 
months ended
 
September
 
30, 2022
 
and 2021.
 
When determining
 
fair value
 
measurements,
 
the Company
 
considers
 
the principal
or most advantageous
 
market in
 
which it
 
would transact
 
and considers
 
assumptions
 
that market
 
participants
 
would use
 
when pricing
 
the
asset. When
 
possible,
 
the Company
 
looks to active
 
and observable
 
markets to
 
price identical
 
assets.
 
When identical
 
assets are
 
not traded
in active
 
markets, the
 
Company
 
looks to market
 
observable
 
data for
 
similar assets.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24
The following
 
table presents
 
financial
 
assets (liabilities)
 
measured
 
at fair value
 
on a recurring
 
basis as of
 
September
 
30, 2022 and
December
 
31, 2021.
 
Derivative
 
contracts
 
are reported
 
as a net
 
position by
 
contract
 
type, and
 
not based
 
on master
 
netting arrangements.
 
(in thousands)
Quoted Prices
in Active
Significant
Markets for
Other
Significant
Identical
 
Observable
Unobservable
Assets
Inputs
Inputs
(Level 1)
(Level 2)
(Level 3)
September 30, 2022
Mortgage-backed securities
$
-
$
3,201,214
$
-
U.S. Treasury Notes
36,118
-
-
Interest rate swaps
-
169,630
-
Interest rate swaptions
-
38,880
-
Interest rate caps
-
1,188
-
TBA securities
-
(394)
-
December 31, 2021
Mortgage-backed securities
$
-
$
6,511,095
$
-
U.S. Treasury Notes
37,175
-
-
Interest rate swaps
-
26,431
-
Interest rate swaptions
-
17,070
-
TBA securities
-
(304)
-
During the nine and three months ended September 30, 2022 and 2021, there were
 
no transfers of financial assets or liabilities
between levels 1, 2 or 3.
NOTE 13. RELATED PARTY TRANSACTIONS
Management Agreement
The Company is externally managed and advised by Bimini Advisors, LLC (the
 
“Manager”) pursuant to the terms of a
management agreement. The management agreement has been renewed
 
through
February 20, 2023
 
and provides for automatic one-
year extension options thereafter and is subject to certain termination rights.
 
Under the terms of the management agreement, the
Manager is responsible for administering the business activities and day-to-day
 
operations of the Company.
 
The Manager receives a
monthly management fee in the amount of:
●
One-twelfth of 1.5% of the first $250 million of the Company’s month-end equity, as defined in the management agreement,
●
One-twelfth of 1.25% of the Company’s month-end equity that is greater than $250
 
million and less than or equal to $500
million, and
●
One-twelfth of 1.00% of the Company’s month-end equity that is greater than $500
 
million.
On April 1, 2022, pursuant to the third amendment to the management agreement
 
entered into on November 16, 2021, the
Manager began providing certain repurchase agreement trading, clearing and
 
administrative services to the Company that had been
previously provided by AVM, L.P.
 
under an agreement terminated on March 31, 2022.
 
In consideration for such services, the Company
will pay the following fees to the Manager:
25
●
A daily fee equal to the outstanding principal balance of repurchase agreement funding
 
in place as of the end of such day
multiplied by 1.5 basis points for the amount of aggregate outstanding principal balance
 
less than or equal to $5 billion, and
multiplied by 1.0 basis point for any amount of aggregate outstanding principal
 
balance in excess of $5 billion, and
●
A fee for the clearing and operational services provided by personnel
 
of the Manager equal to $10,000 per month.
The Company is obligated to reimburse the Manager for any direct expenses incurred
 
on its behalf and to pay the Manager the
Company’s pro rata portion of certain overhead costs set forth in the management
 
agreement.
 
Should the Company terminate the
management agreement without cause, it will pay the Manager a termination
 
fee equal to three times the average annual management
fee, as defined in the management agreement, before or on the last day of the
 
term of the agreement.
Total
 
expenses recorded for the management fee and allocated overhead incurred
 
were approximately $
9.4
 
million and $
3.1
million for the nine and three months ended September 30, 2022, respectively, and $
6.8
 
million and $
2.5
 
million for the nine and three
months ended September 30, 2021, respectively. At September 30, 2022 and December 31, 2021, the net amount due to
 
affiliates was
approximately $
1.1
 
million and $
1.1
 
million, respectively.
Other Relationships with Bimini
Robert Cauley, the Company’s Chief Executive Officer and Chairman of the Board of Directors, also serves as Chief Executive
Officer and Chairman of the Board of Directors of Bimini and owns shares of common
 
stock of Bimini. George H. Haas, IV, the
Company’s Chief Financial Officer, Chief Investment Officer, Secretary and a member of the Board of Directors, also serves as the
Chief Financial Officer, Chief Investment Officer and Treasurer of Bimini and owns shares of common stock of Bimini. In addition, as of
September 30, 2022, Bimini owned
519,871
 
shares, or
1.5
%, of the Company’s common stock.
26
ITEM 2. MANAGEMENT’S
 
DISCUSSION
 
AND ANALYSIS OF FINANCIAL
 
CONDITION
 
AND RESULTS OF
 
OPERATIONS
The following discussion of our financial condition and results of operations should
 
be read in conjunction with the financial
statements and notes to those statements included in Item 1 of this Form 10-Q.
 
The discussion may contain certain forward-looking
statements that involve risks and uncertainties. Forward-looking statements
 
are those that are not historical in nature. As a result of
many factors, such as those set forth under “Risk Factors” in our most recent
 
Annual Report on Form 10-K, our actual results may
differ materially from those anticipated in such forward-looking statements.
Common Stock
 
Reverse
 
Split
On August 30, 2022, the Company effected a 1-for-5 reverse stock split of its common
 
stock and proportionately decreased the
number of authorized shares of common stock.
 
All share and per share information has been retroactively adjusted to reflect
 
the
reverse split.
Overview
We are a specialty finance company that invests in residential mortgage-backed securities
 
(“RMBS”) which are issued and
guaranteed by a federally chartered corporation or agency (“Agency RMBS”).
 
Our investment strategy focuses on, and our portfolio
consists of, two categories of Agency RMBS: (i) traditional pass-through Agency RMBS,
 
such as mortgage pass-through certificates
issued by Fannie Mae, Freddie Mac or Ginnie Mae (the “GSEs”) and collateralized
 
mortgage obligations (“CMOs”) issued by the GSEs
(“PT RMBS”) and (ii) structured Agency RMBS, such as interest-only securities (“IOs”),
 
inverse interest-only securities (“IIOs”) and
principal only securities (“POs”), among other types of structured Agency RMBS.
 
We were formed by Bimini in August 2010,
commenced operations on November 24, 2010 and completed our initial public
 
offering (“IPO”) on February 20, 2013.
 
We are
externally managed by Bimini Advisors, an investment adviser registered with
 
the Securities and Exchange Commission (the “SEC”).
Our business objective is to provide attractive risk-adjusted total returns over the
 
long term through a combination of capital
appreciation and the payment of regular monthly distributions. We intend to achieve this objective
 
by investing in and strategically
allocating capital between the two categories of Agency RMBS described above.
 
We seek to generate income from (i) the net interest
margin on our leveraged PT RMBS portfolio and the leveraged portion
 
of our structured Agency RMBS portfolio, and (ii) the interest
income we generate from the unleveraged portion of our structured Agency RMBS
 
portfolio. We intend to fund our PT RMBS and
certain of our structured Agency RMBS through short-term borrowings
 
structured as repurchase agreements. PT RMBS and structured
Agency RMBS typically exhibit materially different sensitivities to movements in interest
 
rates. Declines in the value of one portfolio
may be offset by appreciation in the other. The percentage of capital that we allocate to our two Agency RMBS asset categories will
vary and will be actively managed in an effort to maintain the level of income generated by
 
the combined portfolios, the stability of that
income stream and the stability of the value of the combined portfolios. We believe that this
 
strategy will enhance our liquidity,
earnings, book value stability and asset selection opportunities in various interest
 
rate environments.
 
We operate so as to qualify to be taxed as a real estate investment trust
 
(“REIT”) under the Internal Revenue Code of 1986, as
amended (the “Code”).
 
We generally will not be subject to U.S. federal income tax to the extent that we
 
currently distribute all of our
REIT taxable income (as defined in the Code) to our stockholders and maintain
 
our REIT qualification.
The Company’s common stock trades on the New York Stock Exchange under the symbol “ORC”.
 
27
Capital Raising Activities
On August 4, 2020, we entered into an equity distribution agreement (the “August
 
2020 Equity Distribution Agreement”) with four
sales agents pursuant to which we could offer and sell, from time to time, up to an aggregate
 
amount of $150,000,000 of shares of our
common stock in transactions that were deemed to be “at the market” offerings and privately
 
negotiated transactions. We issued a total
of 5,538,730 shares under the August 2020 Equity Distribution Agreement for aggregate
 
gross proceeds of approximately $150.0
million, and
 
net proceeds of approximately $147.4 million, after commissions and
 
fees,
 
prior to its termination in June 2021.
On January 20, 2021, we entered into an underwriting agreement (the “January 2021
 
Underwriting Agreement”) with J.P. Morgan
Securities LLC (“J.P. Morgan”), relating to the offer and sale of 1,520,000 shares of our common stock. J.P.
 
Morgan purchased the
shares of our common stock from the Company pursuant to the January 2021
 
Underwriting Agreement at $26.00 per share. In addition,
we granted J.P.
 
Morgan a 30-day option to purchase up to an additional 228,000 shares
 
of our common stock on the same terms and
conditions, which J.P. Morgan exercised in full on January 21, 2021. The closing of the offering of 1,748,000 shares of our common
stock occurred on January 25, 2021, with proceeds to us of approximately $45.2
 
million, net of offering expenses.
On March 2, 2021, we entered into an underwriting agreement (the “March 2021 Underwriting
 
Agreement”) with J.P. Morgan,
relating to the offer and sale of 1,600,000 shares of our common stock. J.P. Morgan purchased the shares of our common stock from
the Company pursuant to the March 2021 Underwriting Agreement at $27.25 per
 
share. In addition, we granted J.P. Morgan a 30-day
option to purchase up to an additional 240,000 shares of our common stock on the same
 
terms and conditions, which J.P. Morgan
exercised in full on March 3, 2021. The closing of the offering of 1,840,000 shares of our common
 
stock occurred on March 5, 2021,
with proceeds to us of approximately $50.0 million, net of offering expenses.
On June 22, 2021, we entered into an equity distribution agreement (the “June 2021
 
Equity Distribution Agreement”) with four
sales agents pursuant to which we could offer and sell, from time to time, up to an aggregate
 
amount of $250,000,000 of shares of our
common stock in transactions that were deemed to be “at the market” offerings and privately
 
negotiated transactions. We issued a total
of 9,881,467 shares under the June 2021 Equity Distribution Agreement for aggregate
 
gross proceeds of approximately $250.0 million,
and net proceeds of approximately $246.2 million, after commissions and fees, prior to
 
its termination in October 2021.
On October 29, 2021,
 
we entered into an equity distribution agreement (the “October 2021
 
Equity Distribution Agreement”) with
four sales agents pursuant to which we may offer and sell, from time to time, up to an aggregate
 
amount of $250,000,000 of shares of
our common stock in transactions that are deemed to be “at the market” offerings and privately negotiated
 
transactions. Through
September 30, 2022, we issued a total of 3,167,140 shares under the October 2021
 
Equity Distribution Agreement for aggregate gross
proceeds of approximately $78.3 million, and net proceeds of approximately
 
$77.0 million, after commissions and fees.
 
Stock Repurchase Agreement
On July 29, 2015, the Company’s Board of Directors authorized the repurchase of up to 400,000
 
shares of our common stock. The
timing, manner, price and amount of any repurchases is determined by the Company in its discretion and is subject
 
to economic and
market conditions, stock price, applicable legal requirements and other factors.
 
The authorization does not obligate the Company to
acquire any particular amount of common stock and the program may be
 
suspended or discontinued at the Company’s discretion
without prior notice. On February 8, 2018, the Board of Directors approved
 
an increase in the stock repurchase program for up to an
additional 904,564 shares of the Company’s common stock. Coupled with the 156,751
 
shares remaining from the original 400,000
share authorization, the increased authorization brought the total authorization
 
to 1,061,316 shares, representing 10% of the
Company’s then outstanding share count.
28
On December 9, 2021, the Board of Directors approved an increase in the
 
number of shares of the Company’s common stock
available in the stock repurchase program for up to an additional 3,372,399 shares, bringing
 
the remaining authorization under the
stock repurchase program to 3,539,861 shares, representing approximately 10% of the
 
Company’s then outstanding shares of
common stock.
 
On October 12, 2022, the Board of Directors approved an increase in the
 
number of shares of the Company’s common stock
available in the stock repurchase program for up to an additional 4,300,000 shares,
 
bringing the remaining authorization under the
stock repurchase program to 6,183,601 shares, representing approximately 18% of the
 
Company’s then outstanding shares of
common stock. This stock repurchase program has no termination date.
From the inception of the stock repurchase program through September 30, 2022, the
 
Company repurchased a total of 1,487,362
shares at an aggregate cost of approximately $44.8 million, including commissions
 
and fees, for a weighted average price of $30.12
per share. During the nine months ended September 30, 2022, the Company repurchased
 
a total of 350,260 shares of its common
stock at an aggregate cost of approximately $4.4 million, including commissions
 
and fees, for a weighted average price of $12.68 per
share. Subsequent to September 30, 2022, and through October 27, 2022, the Company
 
repurchased a total of 1,644,044 shares at an
aggregate cost of approximately $14.2 million, including commissions and fees, for a weighted
 
average price of $8.64 per share.
Factors that Affect our Results of Operations and Financial Condition
A variety of industry and economic factors may impact our results of operations and
 
financial condition. These factors include:
●
interest rate trends;
●
the difference between Agency RMBS yields and our funding and hedging costs;
●
competition for, and supply of, investments in Agency RMBS;
●
actions taken by the U.S. government, including the presidential administration,
 
the Federal Reserve (the “Fed”), the Federal
Housing Financing Agency (the “FHFA”), Federal Housing Administration (the “FHA”), the Federal Open
 
Market Committee
(the “FOMC”) and the U.S. Treasury;
 
●
prepayment rates on mortgages underlying our Agency RMBS and credit
 
trends insofar as they affect prepayment rates; and
●
other market developments.
In addition, a variety of factors relating to our business may also impact our results
 
of operations and financial condition. These
factors include:
●
our degree of leverage;
●
our access to funding and borrowing capacity;
●
our borrowing costs;
●
our hedging activities;
●
the market value of our investments
●
increases in our cost of funds resulting from increases in the Fed Funds rate that
 
are controlled by the Fed which have
occurred, and are likely to continue to occur, in 2022; and
●
the requirements to qualify as a REIT and the requirements to qualify for
 
a registration exemption under the Investment
Company Act.
 
Results
 
of Operations
Described
 
below are
 
the Company’s
 
results of
 
operations
 
for the
 
nine and
 
three months
 
ended September
 
30, 2022,
 
as compared
 
to
the Company’s
 
results of
 
operations
 
for the nine
 
and three
 
months ended
 
September
 
30, 2021.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
29
Net (Loss)
 
Income Summary
Net loss
 
for the nine
 
months ended
 
September
 
30, 2022
 
was $293.4
 
million, or
 
$8.31 per
 
share. Net
 
loss for the
 
nine months
 
ended
September
 
30, 2021
 
was $20.2
 
million, or
 
$0.95 per
 
share.
 
Net loss
 
for the three
 
months ended
 
September
 
30, 2022
 
was $84.5
 
million, or
$2.40 per
 
share. Net
 
income for
 
the three
 
months ended
 
September
 
30, 2021
 
was $26.0
 
million, or
 
$1.00 per
 
share.
 
The components
 
of
net (loss)
 
income for
 
the nine and
 
three months
 
ended September
 
30, 2022
 
and 2021,
 
along with
 
the changes
 
in those components
 
are
presented
 
in the table
 
below:
(in thousands)
Nine Months Ended September 30,
Three Months Ended, September 30,
2022
2021
Change
2022
2021
Change
Interest income
$
112,735
$
90,279
$
22,456
$
35,610
$
34,169
$
1,441
Interest expense
(32,196)
(5,067)
(27,129)
(21,361)
(1,570)
(19,791)
Net interest income
80,539
85,212
(4,673)
14,249
32,599
(18,350)
Losses on RMBS and derivative contracts
(359,059)
(94,522)
(264,537)
(93,544)
(2,887)
(90,657)
Net portfolio (loss) income
(278,520)
(9,310)
(269,210)
(79,295)
29,712
(109,007)
Expenses
(14,859)
(10,886)
(3,973)
(5,218)
(3,674)
(1,544)
Net (loss) income
$
(293,379)